
(
  (S
    (NP
      (NP (NN Development))
      (PP (IN of)
        (NP
          (NP (JJ real-time) (NN NASBA) (NNS assays))
          (PP (IN with)
            (NP (JJ molecular) (NN beacon) (NN detection)))))
      (VP (TO to)
        (VP (VB quantify)
          (NP
            (NP (NN mRNA))
            (VP (VBG coding)
              (PP (IN for)
                (NP (NN HHV-8)))
              (NP
                (ADJP
                  (ADJP (JJ lytic))
                  (CC and)
                  (ADJP (JJ latent)))
                (NNS genes)))))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (NP
      (NP (NN Background))
      (: :)
      (S
        (S
          (NP
            (NP (JJ Human) (NN herpesvirus-8))
            (PRN (-LRB- -LRB-)
              (NP (NN HHV-8))
              (-RRB- -RRB-)))
          (VP (VBZ is)
            (VP (VBN linked)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN pathogenesis))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (NN Kaposi) (POS 's))
                        (NN sarcoma))
                      (PRN (-LRB- -LRB-)
                        (NP (NN KS))
                        (-RRB- -RRB-)))))))))
        (, ,)
        (CC and)
        (S
          (NP
            (NP (DT the) (NN HHV-8) (NN DNA) (NN load))
            (PP (IN in)
              (NP
                (NP (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NN PBMC))
                  (-RRB- -RRB-)))))
          (VP (VBZ is)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP (DT the) (JJ clinical) (NN stage))
                  (PP (IN of)
                    (NP (NN KS)))))))))
      (. .))))

(
  (S
    (VP (TO To)
      (VP (VB examine)
        (NP (DT the) (NN expression)
          (S
            (PP (IN of)
              (NP
                (NP (NN HHV-8))
                (PP (IN in)
                  (NP (NN PBMC)))))
            (, ,)
            (NP (CD four) (NN HHV-8) (NN mRNA) (JJ specific) (NN NASBA) (NNS assays))
            (VP (VBD were)
              (S
                (NP (NNS developedMethodsWe))
                (VP (VBP have)
                  (VP (VBN developed)
                    (NP
                      (NP (CD four) (JJ quantitative) (JJ nucleic) (NN acid) (JJ sequence-based) (NN amplification) (NNS assays))
                      (PRN (-LRB- -LRB-)
                        (NP (NN NASBA-QT))
                        (-RRB- -RRB-)))
                    (S
                      (ADVP (RB specifically))
                      (VP (TO to)
                        (VP (VB detect)
                          (NP (NN mRNA) (NN coding))
                          (PP (IN for)
                            (NP
                              (NP
                                (NP (NN ORF) (CD 73))
                                (PRN (-LRB- -LRB-)
                                  (NP (JJ latency-associated) (JJ nuclear) (NN antigen))
                                  (, ,)
                                  (NP (NN LANA))
                                  (-RRB- -RRB-)))
                              (, ,)
                              (NP
                                (NP (NN vGCR))
                                (PRN (-LRB- -LRB-)
                                  (NP (DT a) (NN membrane) (NN receptor))
                                  (-RRB- -RRB-)))
                              (, ,)
                              (NP
                                (NP (NN vBcl-2))
                                (PRN (-LRB- -LRB-)
                                  (NP
                                    (NP (DT a) (JJ viral) (NN inhibitor))
                                    (PP (IN of)
                                      (NP (NN apoptosis))))
                                  (-RRB- -RRB-)))
                              (CC and)
                              (NP
                                (NP (NN vIL-6))
                                (PRN (-LRB- -LRB-)
                                  (NP (DT a) (JJ viral) (NN growth) (NN factor))
                                  (-RRB- -RRB-))))))))))))
            (. .)))))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN NASBA) (NN technique))
        (VP (VBZ amplifies)
          (NP (JJ nucleic) (NNS acids))
          (PP (IN without)
            (NP
              (NP (NN thermocycling))
              (CC and)
              (NP (NN mRNA))))))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN amplified)
            (PP (IN in)
              (NP (DT a) (JJ dsDNA) (NN background)))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ molecular) (NN beacon))
      (VP (VBZ is)
        (VP (VBN used)
          (PP (IN during)
            (NP (NN amplification)))
          (S
            (VP (TO to)
              (VP (VB enable)
                (NP
                  (NP (JJ real-time) (NN detection))
                  (PP (IN of)
                    (NP (DT the) (NN product))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS assays))
      (VP (VBD were)
        (VP (VBN tested)
          (PP (IN on)
            (NP
              (NP (NN PBMC) (NNS samples))
              (PP (IN of)
                (NP
                  (NP (CD two) (JJ AIDS-KS) (NNS patients))
                  (PP (IN from)
                    (NP (DT the) (NN Amsterdam) (NN Cohort))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Results))
      (: :)
      (S
        (PP (IN For)
          (NP (DT all) (CD four) (NNS assays)))
        (, ,)
        (NP
          (NP
            (NP (DT the) (NN limit))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN detection))
                  (PRN (-LRB- -LRB-)
                    (NP (NN LOD))
                    (-RRB- -RRB-)))
                (PP (IN of)
                  (NP (CD 50) (NNS molecules))))))
          (CC and)
          (NP
            (NP (DT the) (NN limit))
            (PP (IN of)
              (NP
                (NP
                  (NP (NN quantification))
                  (PRN (-LRB- -LRB-)
                    (NP (NN LOQ))
                    (-RRB- -RRB-)))
                (PP (IN of)
                  (NP (CD 100) (NNS molecules)))))))
        (VP (VBD were)
          (VP (VBN determined)
            (S
              (VP (VBG using)
                (NP
                  (ADJP
                    (ADVP (FW in) (FW vitro))
                    (VBN transcribed))
                  (NN RNA)))))))
      (. .))))

(
  (S
    (S
      (NP (DT The) (JJ linear) (JJ dynamic) (NN range))
      (VP (VBD was)
        (NP
          (NP
            (QP (CD 50) (TO to) (CD 107))
            (NNS molecules))
          (PP (IN of)
            (NP (NN HHV-8) (NN mRNA))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (NP (NN HHV-8) (NN mRNA) (NN expression))
        (PP (IN in)
          (NP
            (NP (CD 9))
            (PP (IN out) (IN of)
              (NP (DT the) (CD 10) (VBN tested) (NNS samples)))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Conclusion))
      (: :)
      (S
        (NP
          (NP (DT These) (JJ real-time) (NN NASBA) (NNS assays))
          (PP (IN with)
            (NP (NN beacon) (NN detection))))
        (VP (VBP provide)
          (NP
            (NP (NNS tools))
            (PP (IN for)
              (NP
                (NP (JJ further) (NN study))
                (PP (IN of)
                  (NP
                    (NP (NN HHV-8) (NN expression))
                    (PP (IN in)
                      (NP (NN patient) (NN material))))))))))
      (. .))))

(
  (S
    (NP (NN Background))))

(
  (S
    (S
      (NP
        (NP (JJ Homosexual) (NNS men))
        (VP (VBN infected)
          (PP (IN with)
            (NP (NN HIV-1)))))
      (VP (VBP are)
        (PP (IN at)
          (NP
            (NP (VBN increased) (NN risk))
            (PP (IN for)
              (S
                (VP (VBG developing)
                  (NP
                    (NP (JJ AIDS-related) (NN Kaposi) (POS 's) (NN sarcoma))
                    (PRN (-LRB- -LRB-)
                      (NP (NN AIDS-KS))
                      (-RRB- -RRB-)))
                  (PP (IN due) (TO to)
                    (NP
                      (NP (NN co-infection))
                      (PP (IN with)
                        (NP
                          (NP (NN HHV-8))
                          (, ,)
                          (NP (DT a) (NN gamma) (NN herpes) (NN virus)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB Also))
        (VP (VBN known)
          (PP (IN as)
            (NP
              (ADJP
                (NP (NN Kaposi) (POS 's) (NN sarcoma))
                (JJ associated))
              (NN herpes) (NN virus)))))
      (, ,)
      (NP (NN HHV-8))
      (VP (VBD was)
        (ADVP (RB first))
        (VP (VBN discovered)
          (PP (IN in)
            (NP (CD 1994)))
          (PP (IN in)
            (NP (JJ KS-affected) (NN tissue) (NN -LSB-1)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN Since)
        (NP (RB then)))
      (NP (PRP it))
      (ADVP (RB also))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (JJ multicentric) (NN Castleman) (POS 's) (NN disease))))
                (CC and)
                (NP
                  (NP (JJ primary) (NN effusion) (NN lymphoma))
                  (PRN (-LRB- -LRB-)
                    (NP (NN PEL) (-RRB- -RRB-) (CD -LSB-2-5))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN HHV-8) (NN DNA))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN detected)
            (PP (IN in)
              (NP (CC both)
                (NP (NNS tissues))
                (CC and)
                (NP
                  (NP (JJ bodily) (NNS fluids))
                  (CD -LSB-6,7) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Studies))
      (ADVP (RB initially))
      (VP (VBD focused)
        (PP (IN on)
          (NP
            (NP (NN HHV-8))
            (CC and)
            (NP
              (NP
                (NP (PRP$ its) (NN association))
                (PP (IN with)
                  (NP (NN KS))))
              (, ,)
              (NP
                (NP (NN transmission))
                (PP (IN of)
                  (NP (NN HHV-8))))
              (, ,)
              (CC and)
              (NP
                (NP (DT the) (JJ natural) (NN history))
                (PP (IN of)
                  (NP (NN HHV-8) (NN infection)))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN As)
        (S
          (VP (VBN shown)
            (PP (IN by)
              (NP
                (NP
                  (NP
                    (NP (NNP Renwick) (FW et) (FW al.))
                    (CC and)
                    (NP (NNP Jacobsen) (FW et) (FW al.)))
                  (NN -LSB-8,9) (-RRB- -RSB-) (NN seroconversion))
                (PP (IN for)
                  (NP (NN HHV-8)))
                (PP (IN during)
                  (NP (NN HIV) (NN infection))))))))
      (VP (VBZ increases)
        (NP
          (NP (DT the) (NN risk))
          (PP (IN of)
            (S
              (VP (VBG developing)
                (NP (NN KS))))))
        (, ,)
        (S
          (VP (VBG implying)
            (SBAR (IN that)
              (S
                (NP (NN HIV-1))
                (VP (VBZ has)
                  (NP
                    (NP (DT an) (NN impact))
                    (PP (IN on)
                      (NP (NN HHV-8)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Laboratory) (NNS assays))
        (VP (VBN developed)
          (PP (IN for)
            (NP
              (NP (DT the) (NN detection))
              (PP (IN of)
                (NP (NN HHV-8)))))))
      (VP (VBP include)
        (NP
          (NP
            (NP (JJ serologic) (NNS assays))
            (CONJP (JJ such) (IN as))
            (NP (NN immunofluorescence) (NN antibody) (NNS assays))
            (NP (CD -LSB-10-13) (-RRB- -RSB-)))
          (, ,)
          (NP
            (NP (NN immunoblot) (NNS assays))
            (CD -LSB-10) (-RRB- -RSB-))
          (, ,)
          (CC and)
          (NP
            (NP (JJ various) (NN enzyme) (NNS immunoassays))
            (CD -LSB-14-16) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (JJ PCR-based) (NNS assays))
      (VP (VBP have)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN used)
            (S
              (VP (TO to)
                (VP (VB detect)
                  (NP (NN HHV-8) (NN DNA) (NN -LSB-1))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (PP (IN With)
        (NP (DT the) (JJ serologic) (NNS assays)))
      (, ,)
      (NP
        (NP (NN sensitivity))
        (CC and)
        (NP (NN specificity)))
      (VP (VBP are)
        (ADVP (RB always))
        (ADJP (JJ problematic))))
    (. .)))

(
  (S
    (S
      (NP (DT No) (JJ single) (NN assay))
      (VP (VBZ is)
        (ADVP (RB completely))
        (ADJP
          (ADJP (JJ sensitive))
          (CC and)
          (ADJP (JJ specific))
          (NP (CD -LSB-17))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (MD would)
        (VP (VBP prefer)
          (NP
            (NP (DT a) (NN method))
            (VP (VBG using)
              (NP
                (NP (JJ viral) (NN RNA))
                (CC or)
                (NP (NN DNA)))
              (PP (IN as)
                (NP
                  (NP (DT a) (NN marker))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN presence))
                      (PP (IN of)
                        (NP (NN HHV-8))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Though)
        (S
          (NP (NN DNA))
          (VP (VBZ is)
            (NP (DT an) (JJ obvious) (NN choice))
            (SBAR (IN because)
              (S
                (NP (NN HHV-8))
                (VP (VBZ is)
                  (NP (DT a) (NN DNA) (NN virus))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBP have)
        (VP (VBN chosen)
          (NP (NN RNA))
          (, ,)
          (SBAR (IN because)
            (S
              (NP (PRP it))
              (VP
                (VP (VBZ indicates)
                  (NP
                    (NP (NN activity))
                    (PP (IN of)
                      (NP (DT the) (NN virus)))))
                (CC and)
                (VP (MD may)
                  (ADVP (RB thus))
                  (VP (VB be)
                    (NP (DT a) (JJR better) (JJ prognostic) (NN marker))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Active) (JJ infected) (NNS cells))
      (VP (VBP produce)
        (NP (JJR more) (NN RNA))
        (PP (IN than)
          (NP (NN DNA)))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP (FW In) (FW situ))
        (NN hybridisation))
      (VP (VBZ has)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP
                (NP (JJ most) (NN HHV-8) (JJ infected) (NNS cells))
                (PP (IN in)
                  (NP (NN KS) (NNS lesions))))
              (VP (VBP are)
                (NP
                  (ADJP (RB latently) (JJ infected))
                  (NN -LSB-18,19)))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S (CC but)
      (NP (JJ lytic) (NN HHV-8) (NN infection))
      (VP (VBZ is)
        (ADJP (RB clearly) (JJ present)
          (PP (IN in)
            (NP
              (NP (DT a) (JJ small) (NN proportion))
              (PP (IN of)
                (NP (NNS cells) (CD -LSB-20-22)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN method))
        (PP (IN for)
          (NP
            (NP (DT the) (NN detection))
            (PP (IN of)
              (NP (NN RNA))))))
      (VP (VBZ is)
        (NP (NN RT-PCR))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB increase)
            (NP (NN sensitivity)))))
      (NP (DT an) (JJ additional) (NN amplification) (NN step))
      (VP (MD can)
        (VP (VBP follow)
          (NP (DT the) (NN RT-PCR)))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN method))
      (VP
        (VP (VBZ is)
          (ADJP (NN time) (JJ consuming)))
        (CC and)
        (ADVP (RB also))
        (VP (VBZ increases)
          (NP
            (NP (DT the) (NN likelihood))
            (PP (IN of)
              (NP (JJ false) (JJ positive) (NNS reactions)))
            (PP (JJ due) (TO to)
              (NP (JJ cross-contamination.) (JJ Nucleic) (NN acid)))))))
    (S
      (NP
        (NP (JJ sequence-based) (NN amplification))
        (PRN (-LRB- -LRB-)
          (NP (NN NASBA))
          (-RRB- -RRB-)))
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ single-step) (JJ isothermal) (JJ RNA-specific) (NN amplification) (NN process) (CD -LSB-23) (-RRB- -RSB-))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ amplifies)
                (NP
                  (NP (NN mRNA))
                  (PP (IN in)
                    (NP (DT a) (JJ dsDNA) (NN background) (CD -LSB-24) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN NASBA))
      (VP (VBZ has)
        (VP (VBD proved)
          (ADJP (JJ successful)
            (PP
              (PP (IN in)
                (NP
                  (NP (DT the) (NN detection))
                  (PP (IN of)
                    (NP (JJ various) (NNS mRNAs) (CD -LSB-24-26) (-RRB- -RSB-)))))
              (CC and)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN detection))
                  (PP (IN of)
                    (NP
                      (ADJP (CC both)
                        (ADJP (JJ viral)
                          (NP (CD -LSB-23) (-RRB- -RSB-)))
                        (CC and)
                        (ADJP (JJ bacterial)))
                      (NN -LSB-27) (-RRB- -RSB-) (NN RNA)))
                  (PP (IN in)
                    (NP (JJ clinical) (NNS samples))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN By)
        (S
          (VP (VBG combining)
            (NP (DT the) (JJ standard) (NN NASBA) (NN technology) (CD -LSB-28) (-RRB- -RSB-))
            (PP (IN with)
              (NP
                (NP (DT a) (JJ molecular) (NN beacon))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBZ anneals)
                      (PP (IN during)
                        (NP (NN amplification)))
                      (PP (TO to)
                        (NP (DT the) (NN target) (NN sequence)))))))))))
      (, ,)
      (NP (DT a) (JJ real-time) (NN detection) (NN system))
      (VP (VBZ is)
        (VP (VBN generated)
          (NP (CD -LSB-29) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN paper))
      (VP (VBZ describes)
        (NP
          (NP (PRP$ our) (NN development))
          (PP (IN of)
            (NP (JJ real-time) (NN NASBA) (NNS assays)))
          (S
            (VP (TO to)
              (VP (VB quantify)
                (NP
                  (NP
                    (NP (CD four)
                      (ADJP (RB functionally) (JJ different))
                      (NNS genes))
                    (PP (IN of)
                      (NP (NN HHV-8))))
                  (: :)
                  (NP (NN ORF) (CD 73))
                  (, ,)
                  (NP
                    (NP (DT a) (JJ latent) (NN gene))
                    (, ,)
                    (NP (NN vGCR)))
                  (, ,)
                  (NP (DT a)
                    (ADJP (RB constitutively) (JJ active))
                    (NN gene))
                  (, ,)
                  (CC and)
                  (NP (DT the) (JJ lytic) (NNS genes)
                    (NP
                      (NP (NN vBcl-2))
                      (CC and)
                      (NP (NN vIL-6)))))))))))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB normalise)
          (NP (DT the) (NN input) (NN mRNA)))))
    (NP (PRP we))
    (VP (VBD developed)
      (NP
        (NP (DT a) (JJ fifth) (NN NASBA))
        (PP (IN for)
          (NP
            (NP (DT a)
              (ADJP (RB constitutively) (VBN expressed))
              (NN mRNA))
            (, ,)
            (NP (NN U1A) (NN mRNA))
            (, ,)
            (CC and)
            (NP (NN standardised))
            (NP (DT the) (JJ specific) (NN HHV8) (NNS mRNAs))))
        (PP (TO to)
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP (NN U1A) (NN mRNA)))))))
    (. .)))

(
  (S
    (NP (NNS Methods))))

(
  (S
    (S
      (NP (PRP$ Our) (JJ first) (NN assay))
      (VP
        (VP (VBD was)
          (VP (VBN developed)
            (PP (IN for)
              (NP (NN ORF) (CD 73)))))
        (CC and)
        (VP (VBZ is)
          (VP (VBN based)
            (PP (IN on)
              (NP
                (NP (DT the) (NN amplification))
                (PP (IN of)
                  (NP
                    (NP (DT a) (CD 192) (NN bp) (NN fragment))
                    (ADJP (JJ situated)
                      (PP (IN within)
                        (NP (DT the) (NN gene))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN ORF) (CD 73))
      (VP (VBZ encodes)
        (NP
          (NP
            (NP (DT the) (JJ major) (JJ immunogenic) (JJ latency-associated) (JJ nuclear) (NN antigen))
            (PRN (-LRB- -LRB-)
              (NP (NN LANA))
              (-RRB- -RRB-)))
          (PP (IN of)
            (NP (NN HHV-8))))))
    (. .)))

(
  (S
    (S
      (NP (NN LANA))
      (VP (VBZ is)
        (ADJP (JJ essential)
          (PP (IN for)
            (NP
              (NP (NN maintenance))
              (PP (IN of)
                (NP (DT this) (NN virus))))))
        (PRN
          (PP (IN in)
            (NP
              (ADJP (RB latently) (JJ infected))
              (NNS cells)))
          (NP (CD -LSB-30,31))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP
        (VP (VBZ is)
          (VP (VBN expressed)
            (ADVP (RB only))
            (PP (IN in)
              (NP (JJ such) (NNS cells)))))
        (CC and)
        (VP
          (ADVP (RB thus))
          (VBZ gives)
          (NP
            (NP (DT a) (JJ good) (NN indication))
            (PP (IN of)
              (NP (JJ latent) (NN HHV-8) (NN infection)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP (NN LANA))
      (VP
        (VP (VBZ interacts)
          (PP (IN with)
            (NP (DT the) (NN tumour) (NN suppressor) (NN protein) (NN p53))))
        (CC and)
        (VP (VBZ represses)
          (NP (PRP$ its) (JJ transcriptional) (NN activity) (CD -LSB-32))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (JJ second) (NN assay))
      (VP
        (VP (VBD was)
          (VP (VBN developed)
            (PP (IN for)
              (NP
                (NP (NN vGCR))
                (, ,)
                (NP (NN G-protein) (JJ coupled) (NN receptor))
                (, ,)))))
        (CC and)
        (VP (VBZ amplifies)
          (NP (DT a) (CD 168) (NN bp) (NN fragment)))))
    (. .)))

(
  (S
    (NP
      (NP
        (NP (DT A) (NN receptor))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ binds)
              (NP (JJ several) (NN CXC)
                (CC and)
                (NN CC) (NNS chemokines))))))
      (, ,)
      (NP (NN vGCR)))
    (VP (VBZ appears)
      (S
        (VP (TO to)
          (VP (VB be)
            (NP
              (ADJP (RB constitutively) (JJ active))
              (NN -LSB-33) (-RRB- -RSB-)))))
      (, ,)
      (SBAR (IN although)
        (S
          (NP (DT some) (NNS studies))
          (VP (VBP indicate)
            (SBAR (IN that)
              (S
                (NP (PRP it))
                (VP (VBZ is)
                  (VP (VBN expressed)
                    (ADVP (RB only))
                    (PP (IN during)
                      (NP (JJ lytic) (NN replication) (CD -LSB-34)))
                    (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (MD may)
        (VP (VB contribute)
          (PP (TO to)
            (NP
              (NP (DT the) (NN pathogenesis))
              (PP (IN of)
                (NP (NN KS)))))
          (PP (IN by)
            (S
              (VP (VBG increasing)
                (NP
                  (NP (DT the) (NN release))
                  (PP (IN of)
                    (NP
                      (NP (JJ cellular) (NN growth) (NNS factors))
                      (PP (JJ such) (IN as)
                        (NP (NN VEGF) (NN -LSB-33)))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP
        (VP (VBZ transforms)
          (NP (JJ rodent) (NNS fibroblasts)))
        (CC and)
        (VP (VBZ induces)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP (JJ angiogenic) (NNS factors))))))
      (LST (CD -LSB-35) (-RRB- -RSB-)))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ final) (CD two) (NNS assays))
      (VP (VBD were)
        (VP (VBN developed)
          (PP (IN for)
            (NP (DT the) (NNS genes)
              (NP
                (NP (NN vBcl-2))
                (CC and)
                (NP (NN vIL-6))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT The) (NN assay))
          (PP (IN for)
            (NP (NN vBcl-2))))
        (VP (VBZ amplifies)
          (NP (DT a) (JJ 216-bp) (NN fragment))))
      (, ,)
      (CC and)
      (S
        (PP (IN for)
          (NP (NN vIL-6)))
        (NP (DT the) (NN fragment))
        (VP (VBZ is)
          (NP (CD 186) (NN bp)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN vBcl-2))
        (CC and)
        (NP (NN vIL-6)))
      (VP (VBP are)
        (NP (DT both) (JJ early) (JJ lytic) (NNS genes))
        (, ,)
        (SBAR (IN as)
          (S
            (NP (PRP$ their) (NN expression))
            (VP (VBZ increases)
              (PP (IN within)
                (NP (CD 10) (NNS hours)))
              (PP (IN after)
                (NP (NN induction) (CD -LSB-9) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN vBcl-2))
        (VP (VBZ is)
          (NP
            (NP (DT a) (NN member))
            (PP (IN of)
              (NP (DT the) (NN Bcl-2) (NN family))))))
      (, ,)
      (CC and)
      (S
        (NP (JJ functional) (NNS studies))
        (VP (VBP indicate)
          (SBAR (IN that)
            (S
              (NP (NN vBcl-2))
              (VP
                (VP (VBZ prevents)
                  (NP (JJ Bax-mediated) (NN apoptosis)))
                (CC and)
                (ADVP (RB thus))
                (VP (VBZ is)
                  (NP (DT an) (JJ anti-apoptotic) (NN protein) (NN -LSB-36,37))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (PRP It))
        (VP (VBZ is)
          (ADVP (RB primarily))
          (ADJP (JJ active)
            (PP (IN during)
              (NP (JJ lytic) (NN replication))))))
      (CC and)
      (S
        (NP (PRP$ its) (NN expression) (NN pattern))
        (VP (VBZ suggests)
          (SBAR (IN that)
            (S
              (NP (PRP it))
              (VP (MD may)
                (VP (VB function)
                  (S
                    (VP (TO to)
                      (VP (VB prolong)
                        (NP
                          (NP (DT the) (NN survival))
                          (PP (IN of)
                            (NP (NNS cells)))))
                      (SBAR
                        (WHPP (IN in)
                          (WHNP (WDT which)))
                        (S
                          (NP (JJ lytic) (NN infection))
                          (VP (VBZ is)
                            (ADJP (JJ present))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN vIL-6))
      (VP (VBZ is)
        (NP
          (NP (DT a) (VBN secreted) (NN cytokine))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP
                (VP (VBZ maintains)
                  (NP
                    (NP (NN proliferation))
                    (PP (IN of)
                      (NP (JJ IL-6-dependent) (NN mouse)
                        (CC and)
                        (JJ human) (NN mycelia) (NN cell) (NNS lines)
                        (NP (CD -LSB-21,38,39))
                        (-RRB- -RSB-)))))
                (CC and)
                (VP (VBZ prevents)
                  (NP (NN apoptosis) (CD -LSB-21,38,40) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (NN NASBA) (NN reaction))
      (VP (VBZ is)
        (VP (VBN based)
          (PP (IN on)
            (NP
              (NP (DT the) (JJ simultaneous) (NN activity))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (NP
                        (NP (JJ avian) (NN myeloblastosis) (NN virus))
                        (PRN (-LRB- -LRB-)
                          (NP (NN AMV))
                          (-RRB- -RRB-)))
                      (NP
                        (NP (JJ reverse) (NN transcriptase))
                        (PRN (-LRB- -LRB-)
                          (NP (NN RT))
                          (-RRB- -RRB-))))
                    (, ,)
                    (NP (NN RNase) (NN H))
                    (CC and)
                    (NP (NN T7) (NN RNA) (NN polymerase)))
                  (PP (IN with)
                    (NP (CD two) (NN oligonucleotide) (NNS primers)))
                  (S
                    (VP (TO to)
                      (VP (VB produce)
                        (NP
                          (NP (NN amplification))
                          (PP (IN of)
                            (NP
                              (NP (DT the) (JJ desired) (NN fragment))
                              (ADJP
                                (QP (JJR more) (IN than) (CD 1012))
                                (JJ fold)
                                (PP (IN in)
                                  (NP
                                    (QP (CD 90) (TO to) (CD 120))
                                    (NNS minutes) (CD -LSB-23,41) (-RRB- -RSB-)))))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT a) (NN NASBA) (NN reaction)))
      (, ,)
      (NP (JJ nucleic) (NNS acids))
      (VP (VBP are)
        (NP
          (NP (DT a) (NN template))
          (PP (IN for)
            (NP (DT the) (NN amplification) (NN reaction))))
        (SBAR (RB only) (IN if)
          (S
            (NP (PRP they))
            (VP (VBP are)
              (ADJP
                (ADJP (JJ single) (JJ stranded))
                (CC and)
                (ADJP (JJ located)
                  (PP (IN in)
                    (NP (DT the) (JJ primer-binding) (NN region))))))))))
    (. .)))

(
  (S
    (SBAR (IN Because)
      (S
        (NP (DT the) (NN NASBA) (NN reaction))
        (VP (VBZ is)
          (ADJP
            (ADJP (JJ isothermal))
            (PRN (-LRB- -LRB-)
              (NP (NN 41°C))
              (-RRB- -RRB-))))))
    (, ,)
    (NP
      (NP (JJ specific) (NN amplification))
      (PP (IN of)
        (NP (NN ssRNA))))
    (VP (VBZ is)
      (ADJP (JJ possible))
      (SBAR (IN if)
        (S
          (NP
            (NP (NN denaturation))
            (PP (IN of)
              (NP (NN dsDNA))))
          (VP (VBZ is)
            (VP (VBN prevented)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN sample) (NN preparation))
                  (NN procedure))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADVP (RB thus))
        (ADJP (JJ possible)
          (PP (TO to)
            (NP
              (NP (NN pickup) (NN mRNA))
              (PP (IN in)
                (NP (DT a) (JJ dsDNA) (NN background))))))
        (PP (IN without)
          (S
            (VP (VBG getting)
              (NP
                (NP
                  (ADJP
                    (ADJP (JJ false))
                    (ADJP (JJ positive)))
                  (NNS results))
                (VP (VBN caused)
                  (PP (IN by)
                    (NP (JJ genomic) (NNS dsDNA))))))))
        (, ,)
        (PP (IN in)
          (NP
            (NP (NN contrast))
            (PP (IN with)
              (NP (NN RT-PCR)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN figure) (CD 1)))
      (NP
        (NP (DT a) (JJ schematic) (NN presentation))
        (PP (IN of)
          (NP (DT the) (NN NASBA) (NN amplification))))
      (VP (VBZ is)
        (VP (VBN given))))
    (. .)))

(
  (S
    (S
      (NP (NN NASBA))
      (VP (VBZ is)
        (VP (VBN achieved)
          (PP (IN with)
            (NP
              (NP (DT the) (NN P1) (-LRB- -LRB-) (JJ antisense) (-RRB- -RRB-) (NN –) (NN P2) (-LRB- -LRB-) (NN sense) (-RRB- -RRB-) (NN oligonucleotide))
              (VP (VBN set)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN overhang))
        (PP (IN on)
          (NP (NN P1))))
      (VP (VBZ encodes)
        (NP
          (NP (DT the) (NN promoter) (NN sequence))
          (PP (IN for)
            (NP (DT the) (NN T7) (NN RNA) (NN polymerase))))))
    (. .)))

(
  (S
    (S
      (PP (IN By)
        (S
          (VP (VBG using)
            (NP
              (NP (JJ molecular) (NNS beacons))
              (PP (IN with)
                (NP (DT the) (NN NASBA) (NN amplification)))))))
      (NP (DT a) (JJ real-time) (NN detection) (NN system))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN generated)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Molecular) (NNS beacons))
      (VP (VBP are)
        (NP
          (NP (JJ stem-and-loop-structured) (NNS oligonucleotides))
          (PP (IN with)
            (NP
              (NP (DT a) (JJ fluorescent))
              (VP (VB label)
                (PP (IN at)
                  (NP
                    (NP (DT the)
                      (NP (CD 5))
                      (POS ') (NN end))
                    (CC and)
                    (NP (DT a) (JJ universal) (NN quencher))))
                (PP (IN at)
                  (NP (DT the)
                    (NP (CD 3))
                    (POS ') (NN end)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP They))
      (VP
        (VP (VBP are)
          (ADJP (RB highly) (JJ specific)
            (PP (IN for)
              (NP (PRP$ their) (NN target)))))
        (CC and)
        (VP (VBP hybridise)
          (PP (IN with)
            (NP (PRP$ their) (VBN amplified) (NN target) (NN RNA)))
          (SBAR
            (WHADVP (WRB when))
            (S
              (ADJP (JJ present)
                (PP (IN in)
                  (NP (DT a) (NN NASBA) (NN amplification) (NN reaction)
                    (S
                      (VP (TO to)
                        (VP (VB form)
                          (NP (DT a) (JJ stable) (NN hybrid) (NN -LSB-42) (-RRB- -RSB-))
                          (PP (IN at)
                            (NP
                              (NP (DT a) (JJ relative) (JJ low) (NN temperature))
                              (PRN (-LRB- -LRB-)
                                (NP (NN 41°C))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN NASBA) (NN quantification) (NN method))
      (VP (VBZ is)
        (VP (VBN based)
          (PP (IN on)
            (NP
              (NP (DT a) (JJ standard) (NN curve))
              (PP (IN with)
                (NP
                  (NP (DT a) (JJ known) (NN input))
                  (PP (IN of)
                    (NP (NN RNA))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (DT this) (NN input)))
      (NP (PRP we))
      (VP (VBD used)
        (NP
          (NP
            (ADJP (FW in) (FW vitro))
            (NN RNA))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBD was)
                (VP (VBN transcribed)
                  (PP (IN from)
                    (NP (CD four) (JJ different) (NNS plasmids))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS plasmids))
      (VP (VBD were)
        (VP (VBN generated)
          (PP (IN by)
            (S
              (VP (VBG cloning)
                (NP
                  (NP (DT a) (JJ specific) (NN PCR) (NN product))
                  (PP (IN for)
                    (NP
                      (NP (DT each))
                      (PP (IN of)
                        (NP (DT the) (CD four) (NN target) (NNS genes)))))))))
          (, ,)
          (S
            (VP (VBG using)
              (NP
                (NP (NN primer) (NNS sets))
                (ADJP (JJ located)
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NNS borders))
                      (PP (IN of)
                        (NP (DT the) (JJ different) (NNS genes))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Primer) (NNS sequences))
      (VP (VBP are)
        (VP (VBN shown)
          (PP (IN in)
            (NP (NN table)
              (LST (LS 1.))
              (NN Input)))
          (SBAR (IN for)
            (S
              (NP (DT the) (NN PCR))
              (VP (VBD was)
                (NP
                  (NP (DT the) (JJ nucleic) (NNS acids))
                  (PP (IN of)
                    (NP (DT the) (NN BCP-1) (NN cell) (NN line))))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (DT a) (NN cell) (NN line))
                    (VP (VBG containing)
                      (NP (NN HHV-8))))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS sizes))
        (PP (IN of)
          (NP (DT the) (CD four) (JJ different) (NN PCR) (NNS fragments))))
      (VP (VBD were)
        (NP
          (NP (CD 595) (NN bp))
          (, ,)
          (NP (CD 926) (NN bp))
          (, ,)
          (NP (CD 473) (NN bp))
          (, ,)
          (CC and)
          (NP (CD 589) (NN bp)))
        (PP (IN for)
          (NP
            (NP (NN ORF) (CD 73))
            (, ,)
            (NP (NN vGCR))
            (, ,)
            (NP (NN vBcl-2))
            (CC and)
            (NP (NN vIL-6))))
        (, ,)
        (ADVP
          (ADVP (RB respectively))
          (PRN (-LRB- -LRB-)
            (NP (NN table) (CD 1))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT Each) (NN PCR) (NN fragment))
        (VP (VBD was)
          (VP (VBN cloned)
            (PP (IN into)
              (NP (DT the) (NN TOPO-TA) (NN plasmid)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP Invitrogen/) (NNP Lifetechnologies))
                (, ,)
                (NP (NNP Carlsbad) (, ,) (NNP USA)))
              (-RRB- -RRB-)))))
      (, ,)
      (CC and)
      (S
        (SBAR (IN after)
          (S
            (NP (DT all) (NNS inserts))
            (VP (VBD were)
              (VP (VBN verified)
                (PP (IN by)
                  (NP (NN sequencing)))))))
        (, ,)
        (NP (DT the) (NNS fragments))
        (VP (VBD were)
          (VP (VBN cloned)
            (PP (IN in)
              (NP
                (NP (DT a) (NN plasmide))
                (, ,)
                (NP
                  (NP (NN pBluescript) (NN SK))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (NP (NNP Stratagene))
                        (, ,)
                        (NP (NN La)))
                      (NP (NNP Jolla) (, ,) (NNP USA)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP (FW In) (FW vitro))
        (NN RNA))
      (VP
        (VP (VBD was)
          (VP (VBN generated)
            (PP (IN from)
              (NP
                (NP (DT these) (NNS plasmids))
                (VP (VBG using)
                  (NP
                    (NP (NN T7))
                    (CC or)
                    (NP (NN T3))
                    (NP (NN RNA) (NN polymerase))))))
            (, ,)
            (PP (VBG depending)
              (PP (IN on)
                (NP
                  (NP (DT the) (NN orientation))
                  (PP (IN of)
                    (NP (DT the) (NN fragment))))))))
        (, ,)
        (CC and)
        (VP (VBD was)
          (VP (VBN treated)
            (PP (IN with)
              (NP (NN DNase)))
            (S
              (VP (TO to)
                (VP (VB remove)
                  (NP (DT the) (NN plasmid)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN Q-RNA))
      (VP (VBD was)
        (VP
          (VP (VBN purified)
            (PP (IN by)
              (NP
                (NP (NN RNeasy))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN Qiagen))
                    (, ,)
                    (NP (NNP Hilden) (, ,) (NNP Germany)))
                  (-RRB- -RRB-)))))
          (, ,)
          (VP (VBN quantified)
            (ADVP (RB spectrophotometrically)))
          (, ,)
          (CC and)
          (VP (VBN checked)
            (PP (IN by)
              (NP (NN eye)))
            (PP (IN on)
              (NP (NN agarose) (NN gel)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (VBG resulting)
        (ADJP (FW in) (FW vitro))
        (NN RNA))
      (VP (VBD was)
        (VP (VBN used)
          (PP (IN for)
            (NP (DT the) (CD four) (JJ different) (JJ standard) (NNS curves))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN NASBA) (NN amplification))
        (VP (VBZ requires)
          (NP
            (NP
              (NP (DT a) (NN sense))
              (CC and)
              (NP (DT an) (NN anti-sense)))
            (NN primer))))
      (, ,)
      (CC and)
      (S
        (PP (IN for)
          (NP (JJ real-time) (NN detection)))
        (NP (DT a) (JJ unique) (NN beacon))
        (VP (VBZ is)
          (VP (VBN added)
            (PP (TO to)
              (NP (DT the) (NN reaction)))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD developed)
      (NP
        (NP (JJ molecular) (NNS beacons))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (MD could)
              (VP (VB hybridise)
                (PP (IN with)
                  (NP
                    (NP (DT the) (JJ known) (NNS sequences))
                    (PP (IN of)
                      (NP (DT the) (CD four) (NN HHV-8) (NNS genes))))))
              (, ,)
              (SBAR (IN as)
                (S
                  (VP (VBN shown)
                    (PP (IN in)
                      (NP (NN table)))
                    (S
                      (LST (LS 2.))
                      (NP (PDT All) (DT the) (NNS beacons))
                      (VP (VBP have)
                        (NP
                          (NP
                            (NP
                              (NP (NN 6-fluorescine))
                              (PRN (-LRB- -LRB-)
                                (NP (NN 6-FAM))
                                (-RRB- -RRB-)))
                            (PP (IN as)
                              (NP
                                (NP (DT the) (JJ fluorescent) (VB label))
                                (PP (IN at)
                                  (NP (DT the) (CD 5) ('' ') (NN end))))))
                          (CC and)
                          (NP
                            (NP (DT a)
                              (ADJP (-LRB- -LRB-)
                                (NP (CD 4-) (-LRB- -LRB-) (NN dimethylamino) (-RRB- -RRB-) (NN phenyl) (-RRB- -RRB-) (NN azo))
                                (-RRB- -RRB-) (JJ benzoic))
                              (NN acid))
                            (PRN (-LRB- -LRB-)
                              (NP (NN Dabcyl))
                              (-RRB- -RRB-))))
                        (PP (IN as)
                          (NP (JJ universal) (NN quencher)))
                        (PP (IN at)
                          (NP (DT the) (CD 3) ('' ') (NN end)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN A) (NN BLAST) (NN analysis))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (PP (IN in)
              (NP (DT each) (NN case)))
            (, ,)
            (NP (CC neither)
              (NP (DT the) (NNS primers))
              (CC nor)
              (NP (DT the) (NN beacon)))
            (VP (VBD shared)
              (NP
                (NP (JJ significant) (NN homology))
                (PP (IN with)
                  (NP
                    (NP (DT any) (JJ known) (NN nucleotide) (NNS sequences))
                    (ADJP (JJ other)
                      (PP (IN than)
                        (NP (DT the) (NN target) (NN gene))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN quality))
        (PP (IN of)
          (NP (DT the) (JJ different) (NNS beacons))))
      (VP (VBD was)
        (VP (VBN tested)
          (PP (IN with)
            (NP
              (NP
                (NP (DT a) (JJ melting) (NN curve))
                (PRN (-LRB- -LRB-)
                  (PP (IN from)
                    (NP (CD 80°C) (TO to) (CD 20°C)))
                  (-RRB- -RRB-)))
              (CC and)
              (NP (NN acryl) (NN amide) (NN gel) (NN electrophoresis)))))))
    (. .)))

(
  (S
    (S
      (NP (DT Each) (NN reaction))
      (VP (VBD consisted)
        (PP (IN of)
          (NP
            (NP
              (NP (CD 5) (NN μl))
              (PP (IN of)
                (NP (DT the) (NN sample) (NN RNA))))
            (CC and)
            (NP
              (NP (CD 10) (NN μl))
              (PP (IN of)
                (NP (NN NASBA) (NN reaction) (NN mix))))))))
    (. .)))

(
  (S
    (NP (DT This) (NN mix))
    (VP (VBD consisted)
      (PP (IN of)
        (NP
          (NP
            (ADJP (CD 80) (NN mM))
            (NN Tris-HCl) (NN -LSB-pH) (CD 8.5) (-RRB- -RSB-))
          (, ,)
          (NP
            (ADJP (CD 24) (NN mM))
            (NN MgCl2))
          (, ,)
          (NP
            (ADJP (CD 140) (NN mM))
            (NN KCl))
          (, ,)
          (NP
            (ADJP (CD 1.0) (NN mM))
            (NN DTT))
          (, ,)
          (NP
            (NP (CD 2.0) (NN mM))
            (PP (IN of)
              (NP (DT each) (NN dNTP))))
          (, ,)
          (NP
            (NP
              (NP (CD 4.0) (NN mM))
              (NP (DT each)))
            (PP (IN of)
              (NP
                (NP (NN ATP))
                (, ,)
                (NP
                  (NP (NN UTP))
                  (CC and)
                  (NP (NN CTP)))
                (, ,)
                (NP
                  (ADJP (CD 3.0) (NN mM))
                  (NN GTP))
                (, ,)
                (CC and)
                (NP
                  (ADJP (CD 1.0) (NN mM))
                  (NN ITP))))
            (PP (IN in)
              (NP
                (ADJP (CD 30) (NN %))
                (NN DMSO)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN solution))
      (ADVP (RB also))
      (VP (VBD contained)
        (NP
          (NP
            (NP (DT the)
              (ADJP
                (ADJP (JJ anti-sense))
                (CC and)
                (ADJP (JJ sense)))
              (NNS primers))
            (PP (IN for)
              (NP (NN amplification))))
          (CC and)
          (NP
            (NP (DT the) (JJ molecular) (NNS beacons))
            (VP (VBN used)
              (PP (IN for)
                (NP (NN detection))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ final) (NN concentration))
        (PP (IN for)
          (NP (DT the) (VBZ primes))))
      (VP
        (VP (VBD was)
          (NP (CD 0.1) (NN μM)))
        (CC and)
        (VP
          (PP (IN for)
            (NP (DT the) (NNS beacons)))
          (NP (CD 40) (NN nM)))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NN reaction) (NNS mixtures))
        (VP (VBD were)
          (VP (VBN incubated)
            (PP (IN at)
              (NP (NN 65°C)))
            (PP (IN for)
              (NP (CD 5) (NN min))))))
      (, ,)
      (CC and)
      (S
        (PP (IN after)
          (NP
            (NP (NN cooling))
            (PP (TO to)
              (NP
                (NP (NN 41°C))
                (PP (IN for)
                  (NP (CD 5) (NN min)))
                (S
                  (VP (TO to)
                    (VP (VB allow)
                      (PP (IN for)
                        (NP (NN primer) (NN annealing))))))))))
        (, ,)
        (NP
          (NP (CD 5) (NN μl))
          (PP (IN of)
            (NP (NN enzyme) (NN mix))))
        (VP (VBD was)
          (VP
            (VP (VBN added)
              (PP (IN by)
                (NP (NN pipetting)))
              (PP (IN into)
                (NP
                  (NP (DT the) (NNS lids))
                  (PP (IN of)
                    (NP (DT the) (NNS microtubes))))))
            (CC and)
            (VP
              (ADVP (RB subsequently))
              (VBG spinning)
              (NP (NN down)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN mix))
      (VP (VBD contained) (, ,)
        (PP (IN per)
          (NP
            (NP (NN reaction))
            (, ,)
            (NP (NN 375) (NN mM) (NN sorbitol))
            (, ,)
            (NP (CD 2.1) (NN μg) (NN BSA))
            (, ,)
            (NP
              (ADJP (CD 0.08) (NN U))
              (NN RNase) (NN H))))
        (, ,)
        (NP
          (NP (CD 32) (NN U))
          (NP
            (NP (NN T7) (NN RNA) (NN polymerase))
            (CC and)
            (NP (CD 6.4) (NN U) (NN AMV) (JJ reverse) (NN transcriptase))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Reactions))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN at)
            (NP (NN 41°C)))
          (PP (IN for)
            (NP (CD 120) (NN min)))
          (PP (IN in)
            (NP
              (NP (DT a) (NN fluorometer))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP Cytofluor) (CD 4000))
                  (: ;)
                  (NP (NNP Perkin-Elmer) (, ,) (NNP Wellesley))
                  (, ,)
                  (NP (NNP Mass.)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN RNA) (NNS amplicons))
        (VP (VBN generated)
          (PP (IN in)
            (NP (DT the) (NN NASBA) (NN process)))))
      (VP (VBP are)
        (VP (VBN detected)
          (PP (IN by)
            (NP (JJ molecular) (NNS beacons) (CD -LSB-29) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS beacons))
      (VP (VBP generate)
        (NP (DT a) (JJ fluorescent) (NN signal))
        (PP (IN during)
          (NP (NN amplification)))
        (SBAR
          (WHADVP (WRB when))
          (S
            (VP (VBG hybridising)
              (PP (IN with)
                (NP (PRP$ their) (NN target))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN fluorescence))
      (VP (VBZ is)
        (VP (VBN measured)
          (ADVP (RB continuously))
          (PP (IN during)
            (NP (NN amplification)))
          (PP (IN for)
            (NP
              (NP (JJ real-time) (NN monitoring))
              (PRN (-LRB- -LRB-)
                (PP (FW i.e.))
                (, ,)
                (SBAR (IN as)
                  (S
                    (NP (DT the) (NN reaction))
                    (VP (VBZ proceeds))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (NN threshold))
      (VP (VBZ is)
        (VP (VBN determined)
          (PP (IN by)
            (S
              (VP (VBG setting)
                (NP
                  (NP (DT the) (NN fluorescence))
                  (VP (VBN emitted)
                    (PP (IN in)
                      (NP (DT the) (JJ first) (CD 5) (NN measure) (NNS points)))
                    (PP (IN as)
                      (NP (DT a) (NN background)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN time-point))
        (SBAR
          (WHPP (IN at)
            (WHNP (WDT which)))
          (S
            (NP (DT a) (NN reaction))
            (VP
              (VP (VBZ rises)
                (PP (IN above)
                  (NP
                    (NP (DT this) (NN threshold))
                    (PP (IN of)
                      (NP (NN detection))))))
              (CC and)
              (VP (VBZ becomes)
                (ADJP (JJ positive)))))))
      (VP (VBZ is)
        (VP (VBN determined))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN time-to-positivity) (-LRB- -LRB-) (NN TTP) (-RRB- -RRB-) (NN principle))
      (VP (VBZ is)
        (ADJP (JJ similar)
          (PP (TO to)
            (NP (JJ real-time) (NN PCR) (CD -LSB-43) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ calibration) (NN curve))
        (PP (IN with)
          (NP
            (QP (CD 50) (, ,) (CD 102) (, ,) (CD 103) (, ,) (CD 104) (, ,) (CD 105) (, ,) (CD 106)
              (CC and)
              (CD 107))
            (NNS molecules) (NN HHV-8) (NN mRNA))))
      (VP (VBD was)
        (VP (VBN included)
          (PP (IN in)
            (NP (DT each) (NN experiment))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN number))
        (PP (IN of)
          (NP (NN mRNA) (NNS copies)))
        (PP (IN per)
          (NP (NN sample) (NN input))))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN extrapolated)
            (PP (IN from)
              (NP (DT the) (JJ standard) (NN curve)))))))
    (. .)))

(
  (S
    (S
      (NP (FW De)
        (NP (NNP Baar) (FW et) (FW al)))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (PRP it))
            (VP (VBZ is)
              (ADJP (JJ possible)
                (S
                  (VP (TO to)
                    (VP (VB use)
                      (NP
                        (NP (NN ttp) (NNS values))
                        (PP (IN for)
                          (NP (NN quantification))))
                      (PP (IN without)
                        (NP
                          (NP (DT the) (NN use))
                          (PP (IN of)
                            (NP (DT an) (JJ internal) (NN calibrator) (NN -LSB-44)))))))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP
          (NP (NN standardisation))
          (PP (IN of)
            (NP
              (NP (DT the) (NN amount))
              (PP (IN of)
                (NP (NN RNA) (NN input)))))))
      (NP (DT the) (NN U1A) (NN assay))
      (VP (VBD was)
        (VP (VBN used)
          (PP (IN in)
            (NP (DT each) (NN experiment))))))
    (. .)))

(
  (S
    (S
      (NP (NN U1A) (NN mRNA))
      (VP (VBZ encodes)
        (PP (IN for)
          (NP
            (NP (CD one))
            (PP (IN of)
              (NP
                (NP (DT the) (NNS proteins))
                (PP (IN of)
                  (NP (DT the) (NN U1) (NN snRNP) (CD -LSB-45,46))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (SBAR (IN Because)
        (S
          (NP (NN U1A))
          (VP (VBZ is)
            (ADVP (RB constitutively))
            (VP (VBN expressed)))))
      (, ,)
      (NP
        (NP (DT the) (NN amount))
        (PP (IN of)
          (NP (NN U1A) (NN mRNA)))
        (VP (VBN measured)
          (PP (IN in)
            (NP (DT the) (NNS samples)))))
      (VP (VBZ is)
        (NP
          (NP (DT an) (NN indication))
          (PP (IN of)
            (NP (JJ total) (NN RNA) (NN input))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT The) (NN mean))
          (PP (IN of)
            (NP
              (NP (CD 6) (NNS assays))
              (PRN (-LRB- -LRB-)
                (NP (NN variation) (CD 0.6) (NN log))
                (-RRB- -RRB-)))))
        (VP (VBD was)
          (VP (VBN taken)
            (PP (IN as)
              (NP
                (NP (DT the) (NN input) (NN RNA) (NN amount))
                (PP (IN of)
                  (NP (DT the) (NN sample))))))))
      (, ,)
      (CC and)
      (S
        (NP (NN sample) (NN input) (NN RNA))
        (VP (VBD was)
          (VP (VBN normalised)
            (ADVP (RB accordingly))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN NASBA) (NN conditions))
        (PP (IN for)
          (NP (DT the) (NN U1A) (NN assay))))
      (VP (VBD were)
        (NP
          (NP (DT the) (JJ same))
          (PP (IN as)
            (NP
              (NP (DT those))
              (PP (IN for)
                (NP (DT the) (NN HHV-8) (NN assay))))))
        (, ,)
        (PP (IN with)
          (NP
            (NP (DT the) (NN exception))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ final) (NN concentration))
                (PP (IN of)
                  (NP
                    (NP
                      (NP (DT the) (NN primer))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 0.2) (NN μM))
                        (-RRB- -RRB-)))
                    (CC and)
                    (NP
                      (NP (DT the) (NN beacon))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 50) (NN nM))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN DNA) (NNS fractions))
        (PP (IN of)
          (NP (DT the) (NN PBMC) (NNS samples))))
      (VP (VBD were)
        (VP (VBN tested)
          (PP (IN for)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (NN HHV-8) (NN DNA)))))
          (S
            (VP (VBG using)
              (NP
                (NP (DT a) (JJ nested) (NN PCR))
                (PP (IN for)
                  (NP (NN ORF) (CD 73)))
                (VP (VBN described)
                  (PP (IN by)
                    (NP
                      (NP (NNP Goudsmit) (FW et) (FW al.))
                      (CD -LSB-47) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN As)
        (NP
          (NP (DT a) (NN quantification))
          (PP (IN of)
            (NP
              (NP (DT the) (NN amount))
              (PP (IN of)
                (NP (NN DNA) (NN input)))))))
      (, ,)
      (NP
        (NP (DT a) (JJ limited) (NN dilution) (NN PCR))
        (PP (IN for)
          (NP (DT the) (JJ cellular) (NN CCR5) (NN gene))))
      (VP (VBD was)
        (VP (VBN used))))
    (. .)))

(
  (S
    (S
      (PP (IN With)
        (NP (JJ limited) (NN dilution)))
      (, ,)
      (NP
        (NP (DT an) (NN estimation))
        (PP (IN of)
          (NP
            (NP (NNS copies))
            (PP (IN of)
              (NP (NN HHV-8) (NN DNA))))))
      (VP (VBD was)
        (VP (VBN made)
          (PP (IN in)
            (NP
              (NP (NN relation))
              (PP (TO to)
                (NP
                  (NP (DT the) (NN amount))
                  (PP (IN of)
                    (NP (NNS cells))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (CC both)
          (DT the)
          (NP (NN ORF) (CD 73))
          (CC and)
          (NP (DT the) (NN CCR5) (JJ nested) (NN PCR))))
      (, ,)
      (NP (DT the) (NN detection) (NN level))
      (VP (VBD was)
        (NP (CD 5) (NNS molecules) (NN input))
        (PP (IN per)
          (NP (NN reaction)))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB test)
            (NP (PRP$ our) (NNS assays))
            (ADVP (FW in) (FW vivo)))))
      (, ,)
      (NP (PRP we))
      (VP (VBD selected)
        (NP (NN PBMC) (NNS samples))
        (PP (IN from)
          (NP
            (NP (CD two) (NNS participants))
            (PP (IN of)
              (NP (DT the) (NN Amsterdam) (NN Cohort) (NNS Studies)))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBN Described)
          (ADVP (RB elsewhere))
          (PP (IN in)
            (NP (NN detail) (CD -LSB-48,49))))
        (-RRB- -RSB-))
      (, ,)
      (NP (PRP they))
      (VP
        (VP (VBD were)
          (NP
            (NP (DT both) (JJ HIV-1-infected) (NNS men))
            (PP (IN with)
              (NP
                (NP (NN Kaposi) (POS 's))
                (NN sarcoma)))))
        (CC but)
        (VP (VBD had)
          (NP
            (ADJP (RB very) (JJ different))
            (NN disease) (NN development)))))
    (. .)))

(
  (S
    (S
      (NP (NN Patient) (CD 1))
      (VP (VBD was)
        (NP
          (NP (DT a) (JJ 30-year-old) (NN man))
          (SBAR
            (WHNP (WP who))
            (S
              (VP (VBD was)
                (VP (VBN demonstrated)
                  (S
                    (VP (TO to)
                      (VP (VB be)
                        (ADJP (JJ HIV-1-seropositive)
                          (PP (IN in)
                            (NP (CD 1995))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NNP July) (CD 1996)))
      (NP (NN he))
      (VP (VBD was)
        (VP (VBN diagnosed)
          (PP (IN with)
            (NP (NN KS))))))
    (. .)))

(
  (S
    (S
      (NP (NN He))
      (VP
        (VP (VBD did) (RB not)
          (VP (VB respond)
            (PP (TO to)
              (NP
                (NP
                  (ADJP (JJ anti-retroviral)))
                (CC or)
                (NP (NN chemotherapy))))))
        (CC and)
        (VP (VBD died)
          (PP (IN in)
            (NP
              (NP (NNP January))
              (PP (IN of)
                (NP (CD 1997)))))
          (PP (IN as)
            (NP
              (NP (DT a) (NN result))
              (PP (IN of)
                (NP
                  (NP (JJ severe) (NN infiltration))
                  (PP (IN of)
                    (NP (NN KS)))
                  (PP (IN in)
                    (NP (DT both) (NNS lungs))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Patient) (CD 2))
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ 36-year-old) (NN man))
          (SBAR
            (WHNP (WP who))
            (S
              (VP (VBD visited)
                (NP (PRP$ our) (JJ outpatient) (NN clinic))
                (PP (IN in)
                  (NP (CD 1992)))
                (PP (IN with)
                  (NP
                    (NP (DT an) (VBG increasing) (NN number))
                    (PP (IN of)
                      (NP (JJ KS-related) (NN skin) (NNS lesions)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN After)
          (S
            (VP (VBG he)
              (NP (VBN started) (JJ anti-retroviral) (NN therapy)))))
        (NP (JJ several) (NNS lesions))
        (VP (VBD disappeared)))
      (CC and)
      (S
        (NP (JJ complete) (NN remission))
        (VP (VBD was)
          (ADVP (RB gradually))
          (VP (VBN reached)
            (PP (IN over)
              (NP
                (NP (DT the) (NN course))
                (PP (IN of)
                  (NP (CD two) (NNS years)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (CD two) (NNS patients))
      (VP (VBD were)
        (VP (VBN chosen)
          (PP (IN in)
            (NP (JJ large) (NN part)))
          (PP (IN for)
            (NP
              (NP (DT the) (NN diversity))
              (PP (IN in)
                (NP
                  (NP (PRP$ their) (NN course))
                  (PP (IN of)
                    (NP
                      (NP (NN Kaposi) (POS 's))
                      (NN sarcoma))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD tested)
        (NP
          (NP
            (NP
              (NP
                (NP (CD three) (NNS samples))
                (PP (IN for)
                  (NP (NN patient) (CD 1))))
              (CC and)
              (NP
                (NP (CD seven) (NNS samples))
                (PP (IN for)
                  (NP (NN patient) (CD 2)))))
            (VP (VBN collected)
              (PP (IN over)
                (NP (NN time)))))
          (, ,)
          (NP
            (NP (DT all))
            (VP (VBN taken)
              (PP (IN after)
                (NP
                  (NP (NN diagnosis))
                  (PP (IN of)
                    (NP (NN KS))))))))))
    (. .)))

(
  (S
    (PP (IN After)
      (S
        (NP (DT the) (CD frozen) (NN PBMC) (NNS samples))
        (VP (VBD were)
          (VP (VBN thawed)))))
    (NP (DT the) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN collected))
        (CC and)
        (VP (VBN resuspended)
          (PP (IN in)
            (NP (JJ Trizol™) (NN buffer)))
          (S
            (VP (TO to)
              (VP (VB isolate)
                (NP
                  (NP (NN RNA))
                  (CC and)
                  (NP (NN DNA)))
                (ADVP (RB simultaneously))
                (, ,)
                (PP (VBG according)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NN manufacturer) (POS 's))
                      (NNS recommendations))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Precipitated) (NN RNA))
      (VP (VBD was)
        (ADJP (JJ redissolved))
        (PP (IN in)
          (NP (CD 50) (NNP μl) (NNP H2O)))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (DT each) (NN time-point)))
      (, ,)
      (NP
        (NP (DT a) (JJ known) (NN amount))
        (PP (IN of)
          (NP
            (NP (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NN 7.6–11.1) (NN *) (CD 106) (NNS cells))
              (-RRB- -RRB-)))))
      (VP (VBD were)
        (VP (VBN isolated))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN With)
          (NP
            (NP (JJ high) (NN input))
            (PP (IN of)
              (NP (JJ total) (NN RNA)))))
        (NP (PRP we))
        (VP (VBD found)
          (SBAR (IN that)
            (S
              (NP (NN background) (NN RNA))
              (VP (MD can)
                (VP (VBP disturb)
                  (NP
                    (NP (DT the) (NN amplification))
                    (PP (IN if)
                      (NP (NN present)))
                    (PP (IN in)
                      (NP (JJ large) (NNS amounts))))))))))
      (CC and)
      (S
        (NP (PRP it))
        (VP (VBD was)
          (ADJP (JJ necessary)
            (S
              (VP (TO to)
                (VP (NN dilute)
                  (NP (DT the) (NNS samples)))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB have)
            (NP
              (NP (DT a) (JJ broad) (NN range))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN dilution))
                  (PP (IN for)
                    (NP (DT the) (NN RNA) (NN quantification))))))
            (PP (IN in)
              (NP (DT the) (NN NASBA) (NNS experiments))))))
      (, ,)
      (NP (DT the) (NNS samples))
      (VP (VBD were)
        (VP (VBN diluted)
          (NP
            (QP (CD 10,100) (, ,)
              (CC and)
              (CD 1000))
            (NNS times)))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN Of)
          (NP (DT these) (JJ diluted) (NNS samples)))
        (NP (CD 5) (NN μl))
        (VP (VBD was)
          (VP (VBN used)
            (PP (IN per)
              (NP (NN reaction))))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (CD 10) (NN μl))
          (PP (IN of)
            (NP (NN reaction) (NN mix))))
        (VP (VBD was)
          (VP (VBN added)))))
    (. .)))

(
  (S
    (S
      (NP (NN U1A) (NN mRNA))
      (VP (VBD was)
        (VP (VBN used)
          (PP (IN as)
            (NP (DT an) (JJ external) (JJ standard)))
          (S
            (VP (TO to)
              (VP (VB compare)
                (NP (NN quantification) (NNS signals))
                (PP (IN among)
                  (NP (DT the) (JJ different) (NNS samples)))))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (S
      (NP (DT These)
        (ADJP (RB newly) (VBN developed))
        (NNS assays))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN used)
            (ADVP (RB quantitatively))
            (PP (IN by)
              (S
                (VP (VBG testing)
                  (NP
                    (NP (DT a) (JJ standard) (NN curve))
                    (PP (IN of)
                      (NP
                        (NP (NNS samples))
                        (PP (IN with)
                          (NP
                            (NP (DT a) (JJ known) (NN amount))
                            (PP (IN of)
                              (NP
                                (NP (NN mRNA) (NNS molecules))
                                (PP (IN within)
                                  (NP (DT the) (JJ same) (NN experiment))))))))))
                  (PP (IN as)
                    (NP (DT the) (JJ unknown) (NNS samples)))
                  (, ,)
                  (S
                    (ADVP (RB then))
                    (VP (VBG extrapolating)
                      (NP (DT the) (NNS results))
                      (PP (TO to)
                        (NP (DT the) (JJ standard) (NN curve))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Typical) (NN amplification) (NNS curves))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN plotted)
            (SBAR
              (WHPP (IN in)
                (WHNP (WDT which)))
              (S
                (NP
                  (NP (DT an) (NN increase))
                  (PP (IN of)
                    (NP (NN fluorescence))))
                (VP (VBD was)
                  (VP (VBN observed)
                    (SBAR (IN until)
                      (S
                        (S
                          (NP
                            (NP (JJS most))
                            (PP (IN of)
                              (NP (DT the) (JJ molecular) (NN beacon))))
                          (VP (VBD had)
                            (VP (VBN hybridised)
                              (PP (IN with)
                                (NP (DT the) (VBN synthesised) (NNS amplicons))))))
                        (CC and)
                        (S
                          (NP (DT the) (NN fluorescence))
                          (VP (VBD reached)
                            (NP (DT a) (JJ maximum) (NN level))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (PDT Such) (DT an) (NN amplification))
        (PP (IN of)
          (NP
            (ADJP
              (ADVP (FW in) (FW vitro))
              (VBN synthesised))
            (NN ORF) (CD 73) (NN RNA))))
      (VP (VBZ is)
        (VP (VBN shown)
          (PP (IN in)
            (NP
              (NP (DT the) (NN insert))
              (PP (IN in)
                (NP (NN figure) (NN 2a))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (DT The) (NN time-point))
          (SBAR
            (WHPP (IN at)
              (WHNP (WDT which)))
            (S
              (NP (DT the) (NN fluorescence) (NN signal))
              (VP (VBD became)
                (ADJP (JJ detectable))
                (PP (IN over)
                  (NP (DT the) (NN background)))
                (PP (FW i.e.))))))
        (, ,)
        (NP
          (NP (NN time-to-positivity))
          (PRN (-LRB- -LRB-)
            (NP (NN ttp))
            (-RRB- -RRB-)))
        (, ,))
      (VP (VBD was)
        (ADJP (JJ linear))
        (PP (IN over)
          (NP
            (NP (DT a) (NN range))
            (PP (IN of)
              (NP
                (NP
                  (QP (IN at) (JJS least) (CD six))
                  (NNS orders))
                (PP (IN of)
                  (NP
                    (NP (NN magnitude))
                    (PP (IN of)
                      (NP (NN input) (NN RNA) (NNS molecules)))))))))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBN shown)
              (PP (IN by)
                (NP
                  (NP (DT the) (NN dilution) (NN series))
                  (PP (IN of)
                    (NP
                      (ADJP
                        (ADVP (FW in) (FW vitro))
                        (VBN synthesised))
                      (NN RNA))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN figure) (NN 2a)))
      (NP
        (NP (DT the) (NN relationship))
        (PP (IN between)
          (NP
            (NP (NN ttp) (NNS values))
            (PP (IN of)
              (NP
                (NP
                  (NP (DT the) (JJ standard) (NN curve))
                  (PP (IN for)
                    (NP (NN ORF) (CD 73))))
                (CC and)
                (NP
                  (NP (DT the) (NN log) (NN input))
                  (PP (IN of)
                    (NP
                      (ADJP (FW in) (FW vitro))
                      (NN RNA)))))))))
      (VP (VBZ is)
        (VP (VBN shown))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN relationship))
      (VP (VBD extended)
        (PP (IN from)
          (NP
            (QP (CD 107) (TO to) (CD 50))
            (NNS molecules) (NN input)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN dilution) (NN series))
        (PP (IN of)
          (NP
            (ADJP (FW in) (FW vitro))
            (NN RNA))))
      (VP (VBD showed)
        (NP
          (NP (DT a) (NN detection) (NN level))
          (PP (IN of)
            (NP (CD 50) (NNS molecules) (NN input))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (JJ accurate) (NN quantification)))
      (NP (DT the) (JJ required) (NN level))
      (VP (VBZ is)
        (NP (CD 102) (NNS molecules) (NN input))
        (PP (IN per)
          (NP (NN assay)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN line))
      (VP (VBZ is)
        (VP (VBN calculated)
          (PP (IN with)
            (NP (JJ linear) (NN regression) (NN analysis))))))
    (. .)))

(
  (S
    (S
      (PP (IN Besides)
        (NP
          (NP (DT the) (NN limit))
          (PP (IN of)
            (NP
              (NP (NN detection))
              (PRN (-LRB- -LRB-)
                (NP (NN LOD))
                (-RRB- -RRB-))))))
      (, ,)
      (NP
        (NP (DT the) (NN limit))
        (PP (IN of)
          (NP
            (NP (NN quantification))
            (PRN (-LRB- -LRB-)
              (NP (NN LOQ))
              (-RRB- -RRB-)))))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN determined)))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (NN ORF) (CD 73)))
      (, ,)
      (NP (DT the) (NN LOD))
      (VP (VBZ is)
        (NP
          (NP (CD 50) (NNS molecules) (NN input))
          (PRN (-LRB- -LRB-)
            (NP (CD 84) (NN %) (CD pos.))
            (-RRB- -RRB-)))
        (SBAR (IN while)
          (S
            (NP (DT the) (NN LOQ))
            (VP (VBZ is)
              (NP
                (NP (CD 102) (NNS molecules))
                (PP (IN per)
                  (NP (NN reaction)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ linear) (NN quantification))
        (PP (IN of)
          (NP
            (NP (DT the) (NN ORF))
            (ADJP (CD 73) (NN assay)))))
      (VP (VBD was)
        (VP (VBN determined)
          (S
            (VP (TO to)
              (VP (VB be)
                (PP (IN between)
                  (NP
                    (NP
                      (QP (CD 102) (TO to) (CD 107))
                      (NNS copies))
                    (PP
                      (NP (NN RNA))
                      (IN per)
                      (NP
                        (NP (NN reaction))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN R) (CD 2))
                            (ADJP (JJ =)
                              (NP (CD 0.96))))
                          (, ,)
                          (NP (NN p) (NN <) (CD 0.001))
                          (, ,)
                          (NP (NN fig)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN 2a))
      (-RRB- -RRB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN sensitivity))
        (PP (IN of)
          (NP (DT all) (CD four) (NNS assays))))
      (VP (VBD was)
        (VP (VBN studied)
          (S
            (VP (VBG using)
              (NP (CD five) (JJ serial) (NNS dilutions)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN linear) (NN regression) (NNS analyses))
        (PP (IN for)
          (NP (DT the) (JJ other) (NNS assays))))
      (VP (VBP are)
        (VP (VBN shown)
          (PP (IN in)
            (NP (NN figure) (NN 2b,2c,2d,2e))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT The) (NN assay))
          (PP (IN for)
            (NP (NN vGCR))))
        (VP (VBZ has)
          (NP (DT a)
            (ADJP (RB very) (JJ small))
            (JJ standard) (NN deviation))))
      (, ,)
      (CC and)
      (S
        (NP (DT the) (NN amplification))
        (VP (VBZ is)
          (ADJP (JJ linear))
          (PP (IN from)
            (NP
              (QP (CD 107) (TO to) (CD 50))
              (NNS molecules) (NN input)))
          (PP (IN per)
            (NP (NN reaction)))
          (PRN (-LRB- -LRB-)
            (NP (NN R) (CD 2) (NNP >) (CD 0.99) (, ,)
              (NP (NN p) (JJ <) (CD 0.001))
              (, ,)
              (NP (NN fig)))))))
    (. .)))

(
  (S
    (S
      (NP (NN 2b))
      (-RRB- -RRB-))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NN LOD))
        (VP (VBZ is)
          (NP
            (NP (CD 50) (NNS molecules))
            (PRN (-LRB- -LRB-)
              (NP (CD 55) (NN %) (CD pos.))
              (-RRB- -RRB-)))))
      (CC and)
      (S
        (NP (DT the) (NN LOQ))
        (VP (VBZ is)
          (NP
            (NP (CD 102) (NNS molecules))
            (PP (IN per)
              (NP (NN reaction)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS assays))
        (PP (IN for)
          (NP (CC both)
            (NP (NN vBcl-2))
            (CC and)
            (NP (NN vIL-6)))))
      (VP
        (VP (VBP are)
          (ADJP (JJR weaker)))
        (CC but)
        (VP
          (ADVP (RB still))
          (PP (IN within)
            (NP (DT a) (JJ workable) (NN range))))))
    (. .)))

(
  (S
    (PP (IN As)
      (NP (JJ above)))
    (, ,)
    (NP (DT the) (JJ linear) (NN quantification))
    (VP (VBD was)
      (PP (IN between)
        (S
          (S
            (NP
              (QP (CD 102) (TO to) (CD 107))
              (NNS copies) (NN RNA) (IN per) (NN reaction) (-LRB- -LRB-) (NN R) (CD 2))
            (VP (JJ =)
              (NP (CD 0.94))))
          (CC and)
          (S
            (NP (NN R) (CD 2))
            (VP (JJ =)
              (NP (CD 0.95)
                (ADVP (RB respectively))
                (, ,)
                (NP (NN p) (JJ <) (CD 0.001))
                (, ,)
                (NP (NN fig))))))))
    (. .)))

(
  (S
    (S
      (NP (NN 2c,2d))
      (-RRB- -RRB-))
    (. .)))

(
  (S
    (PP (IN For)
      (NP (DT both) (NNS assays)))
    (, ,)
    (NP (DT the) (NN LOD))
    (VP (VBZ is)
      (NP
        (NP
          (NP (CD 50) (NNS molecules))
          (PRN (-LRB- -LRB-)
            (NP (CD 72) (NN %))))
        (CC and)
        (NP
          (ADJP (CD 50) (NN %))
          (NN pos))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB respectively))
        (-RRB- -RRB-))
      (CC and)
      (S
        (NP (DT the) (NN LOQ))
        (VP (VBZ is)
          (NP
            (NP (CD 102) (NNS molecules))
            (PP (IN per)
              (NP (NN reaction)))))))
    (. .)))

(
  (S
    (S
      (NP (NN U1A))
      (VP (VBZ has)
        (NP
          (NP (DT a) (JJ linear) (NN quantification) (NN range))
          (PP (IN of)
            (NP
              (NP
                (QP (CD 103) (TO to) (CD 108))
                (NNS molecules))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN R2))
                  (ADJP (JJ =)
                    (NP (CD 0.99))))
                (, ,)
                (NP (NN p) (NN <) (CD 0.001))
                (, ,)
                (NP (NN fig) (NNS 2e))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN assay))
        (PP (IN for)
          (NP (NN U1A))))
      (VP (VBD had)
        (NP
          (NP (DT a) (NN sensitivity))
          (PP (IN of)
            (NP
              (QP (RB only) (CD 103))
              (NNS copies) (NN input/reaction)))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBZ is)
                (ADJP (JJ feasible)
                  (PP (JJ due) (TO to)
                    (NP
                      (NP (DT the) (JJ high) (NN expression) (NN level))
                      (PP (IN of)
                        (NP (NN U1A))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN specificity))
        (PP (IN of)
          (NP (DT the) (CD five) (NNS assays))))
      (VP (VBD was)
        (VP (VBN tested)
          (PP (IN by)
            (S
              (VP (VBG spiking)
                (NP (DT each) (NN reaction))
                (PP (IN with)
                  (NP
                    (NP (CD 106) (NNS molecules))
                    (PP (IN of)
                      (NP
                        (ADJP (FW in) (FW vitro))
                        (NN RNA)))))
                (SBAR (IN that)
                  (S
                    (NP
                      (NP (DT the) (NNS primers))
                      (CC and)
                      (NP (NN beacon)))
                    (VP (VBD were) (RB not)
                      (VP (VBN designed)
                        (PP (IN for))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (NN example)))
      (, ,)
      (NP
        (NP (NN ORF) (CD 73))
        (NP
          (ADJP (FW in) (FW vitro))
          (NN RNA)))
      (VP (VBD did) (RB not)
        (VP (VB give)
          (NP
            (NP (DT a) (NN signal))
            (PP (IN with)
              (NP (DT the) (NN vGCR) (NN assay))))
          (PRN (-LRB- -LRB-)
            (S
              (NP (NNS data))
              (VP (RB not) (VBN shown)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (VB replicate)
          (NP (JJ independent) (NNS experiments))))
      (, ,)
      (NP (DT the) (NN time-to-positivity) (-LRB- -LRB-) (NN TTP) (-RRB- -RRB-) (NN value))
      (VP (VBD had)
        (NP
          (NP (DT a) (JJ linear) (NN relationship))
          (PP (IN with)
            (NP
              (NP (DT the) (NN logarithm))
              (PP (IN of)
                (NP
                  (NP (DT the) (NN amount))
                  (PP (IN of)
                    (NP
                      (ADJP (FW in) (FW vitro))
                      (NN RNA)))
                  (VP (VBN added)
                    (PP (IN in)
                      (NP (DT the) (NN reaction)))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Subsequent) (NNS experiments))
      (VP (VBD used)
        (NP
          (NP (JJ serial) (JJ 10-fold) (NNS dilutions))
          (PP (IN of)
            (NP
              (NP
                (ADJP (FW in) (FW vitro))
                (NN RNA))
              (-LRB- -LRB-)
              (PP (IN from)
                (NP
                  (NP
                    (QP (CD 107) (TO to) (CD 102)
                      (CC and)
                      (CD 50))
                    (NNS molecules))
                  (PP (IN per)
                    (NP (NN reaction)))))
              (-RRB- -RRB-))))
        (PP (IN as)
          (NP (DT a) (JJ standard) (NN curve)))
        (S
          (VP (TO to)
            (VP (VB determine)
              (NP
                (NP (DT the) (NN amount))
                (PP (IN of)
                  (NP (NN HHV-8) (NN RNA)))
                (PP (IN in)
                  (NP (NNS samples)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS experiments))
      (VP (VBD were)
        (VP (VBN done)
          (PP
            (PP (IN on)
              (NP (JJ different) (NNS days)))
            (CC and)
            (PP (IN by)
              (NP
                (NP (JJ different) (NN people))
                (PP (IN with)
                  (NP
                    (NP (DT no) (JJ significant) (NN variation))
                    (PP (IN in)
                      (NP
                        (NP (NNS results))
                        (, ,)
                        (SBAR
                          (WHNP (WDT which))
                          (S
                            (VP
                              (VP (VBD confirmed)
                                (NP
                                  (NP (DT the) (NN robustness))
                                  (PP (IN of)
                                    (NP (DT the) (NNS assays)))))
                              (CC and)
                              (VP
                                (ADVP (RB also))
                                (NP
                                  (NP (PRP$ their) (NN ease))
                                  (PP (IN of)
                                    (NP (NN performance))))))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB address)
            (NP
              (NP (DT the)
                (NP (NN functionality))
                (CC and)
                (NP (NN quality)))
              (PP (IN of)
                (NP (DT the) (NN HHV-8) (NNS assays)))
              (ADVP (FW in) (FW vivo))))))
      (, ,)
      (NP (PRP they))
      (VP (VBD were)
        (VP (VBN tested)
          (PP (IN on)
            (NP
              (NP (NN PBMC) (NNS samples))
              (VP (VBN collected)
                (PP (IN after)
                  (NP (NN KS) (NN diagnosis)))
                (PP (IN from)
                  (NP
                    (NP (CD two) (NNS participants))
                    (PP (IN in)
                      (NP (DT the) (NN Amsterdam) (NN Cohort) (NNS Studies)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN total)))
      (, ,)
      (NP (CD 10) (JJ frozen) (NNS samples))
      (VP (VBD were)
        (VP (VBN analysed))))
    (. .)))

(
  (S
    (S
      (PP (IN As)
        (NP (DT a) (JJ positive) (NN control)))
      (, ,)
      (NP (DT all) (NNS samples))
      (VP
        (VP (VBD were)
          (VP (VBN tested)
            (PP (IN for)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP (NN HHV-8) (NN DNA)))))
            (PP (IN with)
              (NP (DT a) (JJ nested) (NN PCR)))))
        (CC and)
        (VP (VBD were)
          (VP (VBN found)
            (S
              (VP (TO to)
                (VP (VB be)
                  (ADJP (JJ positive)))))
            (PRN (-LRB- -LRB-)
              (S
                (VP (VB see)
                  (NP
                    (NP (NNS Materials))
                    (CC and)
                    (NP (NNS Methods)))))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS copies))
        (PP (IN of)
          (NP (NN HHV-8) (NN DNA))))
      (VP (VBD varied)
        (PP (IN between)
          (NP (CD 2)
            (CC and)
            (CD 2) (NN *) (CD 102)))
        (PP (IN per)
          (NP (CD 103) (NNS cells)))
        (PRN (-LRB- -LRB-)
          (NP (NN table) (CD 3))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (NN relation))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NN HHV-8) (NN DNA) (NNS levels))
                  (PP (IN in)
                    (NP (NN PBMC))))
                (CC and)
                (NP
                  (NP (DT the) (NN extent))
                  (PP (IN of)
                    (NP (NN Kaposi) (POS 's) (NN sarcoma) (CD -LSB-50) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ possible) (NN correlation))
        (PP (IN between)
          (NP
            (NP (NN DNA) (NNS levels))
            (CC and)
            (NP (NN mRNA) (NN expression)))))
      (VP (MD should)
        (VP (VB be)
          (VP (VBN investigated)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS results))
        (PP (IN of)
          (NP (DT the) (NN HHV-8) (NNS assays))))
      (VP (VBP are)
        (VP (VBN shown)
          (SBAR (IN in) (NN table)
            (S
              (LST (LS 3.))
              (PP (IN Of)
                (NP (DT the) (CD 10) (NNS samples)))
              (, ,)
              (NP (CD 9))
              (VP (VBD were)
                (ADJP (JJ positive)
                  (PP (IN for)
                    (NP (NN ORF) (CD 73))))
                (, ,)
                (SBAR (IN whereas)
                  (S
                    (NP (RB only) (NN half))
                    (VP (VBD were)
                      (ADJP (JJ positive)
                        (PP (IN for)
                          (NP (NN vGCR)))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN While)
        (S
          (NP (NN vBcl-2))
          (VP (VBD was)
            (VP (VBN measured)
              (PP (IN in)
                (NP
                  (QP (CD 9) (IN out) (IN of) (CD 10))
                  (NNS samples)))))))
      (, ,)
      (NP (NN vIL-6))
      (VP (VBD was)
        (VP (VBN detected)
          (PP (IN in)
            (NP
              (NP (RB approximately) (NN half))
              (PP (IN of)
                (NP (DT the) (NNS samples))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (PDT All) (DT the) (NNS samples))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBD were)
              (ADJP (JJ positive)
                (PP (IN for)
                  (NP (NN ORF) (CD 73))))))))
      (VP (VBD were)
        (ADVP (RB also))
        (ADJP (JJ positive)
          (PP (IN for)
            (NP (NN vBcl-2))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Surprisingly))
      (NP (DT the) (NNS samples))
      (VP (VBD were)
        (ADJP (JJ positive))
        (PP (IN for)
          (NP (DT a)
            (ADJP
              (ADJP (JJ latent))
              (CC and)
              (ADJP (NN a) (JJ lytic)))
            (NN gene)))
        (PP (IN at)
          (NP (DT the) (JJ same) (NN time)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN variation))
        (PP (IN in)
          (NP (NN expression) (NNS levels))))
      (VP (VBZ is)
        (ADJP (JJ large))
        (PP (CC both)
          (PP (IN among)
            (NP (DT the) (JJ different) (NNS assays)))
          (CC and)
          (PP (IN among)
            (NP (DT the) (NNS samples))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT No) (JJ clear) (NN trend))
        (PP (IN in)
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP (JJ HHV-8-specific) (NN mRNA))))))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN distinguished) (, ,)
            (PP (VBN based)
              (PP (IN on)
                (NP
                  (NP (NN HHV-8) (NN DNA) (NNS levels))
                  (, ,)
                  (NP (NN patient))
                  (, ,)
                  (CC or)
                  (NP (NN disease) (NN status)))))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (PP (IN In)
        (NP (JJ general)))
      (NP (DT the) (NN NASBA) (NN assay))
      (VP (VBZ has)
        (NP (JJ several) (NNS advantages))
        (PP (IN over)
          (NP (DT the) (NN PCR) (NN technique) (CD -LSB-51) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN amplification) (NN procedure))
        (PP (IN of)
          (NP (DT the) (NN NASBA) (NN assay))))
      (VP
        (VP (VBZ is)
          (ADVP (RB entirely))
          (ADJP (JJ isothermal)))
        (CC and)
        (VP (VBZ is)
          (VP (VBN conducted)
            (PP (IN at)
              (NP (NN 41°C)))))))
    (: ;)
    (S
      (NP (PRP it))
      (VP (VBZ does) (RB not)
        (VP (VB require)
          (NP (JJ thermal) (NN cycling) (NN instrumentation)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN NASBA) (NN product))
      (VP
        (VP (VBZ is)
          (ADJP (JJ single-stranded)))
        (CC and)
        (VP (MD can)
          (ADVP (RB therefore))
          (VP (VB be)
            (ADVP (RB readily))
            (VP (VBN detected)
              (PP (IN by)
                (NP (NN hybridisation) (NN analysis))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (CD four) (JJ real-time) (NN NASBA) (NNS assays))
      (VP
        (VP (VB offer)
          (NP (DT these) (NNS benefits)))
        (CC and)
        (VP
          (ADVP (RB also))
          (NP
            (NP
              (NP (DT the) (CD five) (NNS features))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP define)
                    (NP
                      (NP (NN validation))
                      (PP (IN of)
                        (NP (DT any) (NN assay))))))))
            (: :)
            (NP
              (NP (NN accuracy))
              (, ,)
              (NP (NN sensitivity))
              (, ,)
              (NP (NN precision))
              (, ,)
              (NP (NN robustness))
              (, ,)
              (CC and)
              (NP (NN specificity)))))))
    (. .)))

(
  (S
    (S
      (PP (IN With)
        (NP
          (NP (DT the) (NN use))
          (PP (IN of)
            (NP (JJ standard) (NNS curves)))
          (PP (IN in)
            (NP (DT each) (NN experiment)))))
      (, ,)
      (NP (NN accuracy))
      (VP (VBZ is)
        (VP (VBN achieved))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN sensitivity))
      (VP (VBZ is)
        (VP (VBN determined)
          (PP (IN with)
            (NP (DT a) (JJ linear) (JJ standard) (NN curve))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (DT The) (NN limit))
            (PP (IN of)
              (NP (NN detection))))
          (PRN (-LRB- -LRB-)
            (NP (NN LOD))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP
            (NP (DT the) (NN limit))
            (PP (IN of)
              (NP (NN quantification))))
          (PRN (-LRB- -LRB-)
            (NP (NN LOQ))
            (-RRB- -RRB-))))
      (VP (VBP are)
        (VP (VBN determined))))
    (. .)))

(
  (S
    (PP (IN For)
      (NP (PDT all) (DT the) (NN HHV-8) (NNS assays)))
    (, ,)
    (NP (DT the) (NN LOD))
    (VP (VBZ is)
      (NP
        (NP (CD 50) (NNS molecules))
        (SBAR (IN per)
          (S
            (NP
              (NP (NN reaction))
              (CC and)
              (NP (NN LOQ)))
            (VP (VBD was)
              (NP
                (NP (CD 100) (NNS molecules))
                (PP (IN per)
                  (NP (NN reaction)))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB achieve)
            (NP (JJ linear) (NN amplification)))))
      (VP (VBZ requires)
        (NP
          (QP (IN at) (JJS least) (CD 5))
          (NNS concentrations))
        (PP (IN on)
          (NP
            (NP (DT the) (JJ linear) (NN portion))
            (PP (IN of)
              (NP (DT the) (NN curve)))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN For)
          (NP (DT the) (NN HHV-8) (NNS assays)))
        (, ,)
        (NP (DT the) (JJ linear) (NN range))
        (VP (VBZ spans)
          (NP (CD 7) (NNS concentrations))))
      (CC and)
      (S
        (PP (IN for)
          (NP (NN U1A)))
        (NP (PRP it))
        (VP (VBZ spans)
          (NP (CD 6) (NNS concentrations)))))
    (. .)))

(
  (S
    (S
      (NP (NN Quantification))
      (VP (VBD was)
        (VP (VBN achieved)
          (PP (IN within)
            (NP
              (NP
                (NP (DT this) (JJ linear) (NN range))
                (PP (IN of)
                  (NP
                    (NP
                      (QP (IN at) (JJS least) (CD six))
                      (NNS orders))
                    (PP (IN of)
                      (NP (NN magnitude))))))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP
                    (QP (CD 102) (TO to) (CD 107))
                    (NNS molecules))
                  (PP (IN per)
                    (NP (NN reaction))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN Within)
        (NP (DT this) (JJ linear) (NN range)))
      (NP
        (NP (NN quantification))
        (PP (IN of)
          (NP
            (NP
              (NP
                (QP (IN at) (JJS least) (CD six))
                (NNS orders))
              (PP (IN of)
                (NP (NN magnitude))))
            (PRN (-LRB- -LRB-)
              (NP
                (NP
                  (QP (CD 102) (TO to) (CD 107))
                  (NNS molecules))
                (PP (IN per)
                  (NP (NN reaction))))
              (-RRB- -RRB-)))))
      (VP (VBD was)
        (VP (VBN achieved))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN precision))
        (PP (IN of)
          (NP (DT the) (NNS assays))))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN as)
            (NP
              (NP (DT the) (JJ standard) (NN deviation))
              (CC and)
              (NP
                (NP (DT the) (NN confidence) (NN interval))
                (PRN (-LRB- -LRB-)
                  (NP (NN fig)))))))))
    (. .)))

(
  (S
    (S
      (NP (CD 2))
      (-RRB- -RRB-))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD used)
        (NP
          (NP (LS 5) (VBZ replicates))
          (PP (IN of)
            (NP
              (NP (CD 7) (JJ different) (NNS concentrations))
              (PP (IN of)
                (NP (DT the) (JJ standard) (NN curve))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Robustness))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN by)
            (S
              (VP (VBG having)
                (NP (JJ different) (NN people))
                (VP (VB perform)
                  (NP
                    (NP (DT the) (NNS experiments))
                    (PP (IN on)
                      (NP (JJ different) (NNS days)))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Specificity))
      (VP (VBD was)
        (VP (VBN shown)
          (PP (IN with)
            (NP (JJ spiking) (NNS experiments))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJR lower) (NN detection) (NN level))
        (PP (IN of)
          (NP (DT the) (NNS assays))))
      (VP (VBD was)
        (NP
          (QP (RB approximately) (CD 50))
          (NNS copies))
        (PP (IN per)
          (NP (NN reaction)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS assays))
      (VP (VBP work)
        (ADVP (RB equally) (RB well))
        (ADVP (FW in) (FW vivo))
        (PP (IN as)
          (ADJP (FW in) (FW vitro) (FW e.g.)))
        (, ,)
        (PP (IN for)
          (NP
            (NP (NN quantification))
            (PP (IN of)
              (NP
                (NP (NN HHV-8) (NN RNA))
                (PP (IN in)
                  (NP (NNS PBMCs)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT The) (NN onset))
          (PP (IN of)
            (NP (NN KS))))
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP (DT a) (JJ high) (NN HHV-8) (NN load))
                (PP (IN in)
                  (NP (NN PBMC) (CD -LSB-19) (-RRB- -RSB-))))))))
      (CC and)
      (S
        (NP (DT this))
        (VP (VBZ indicates)
          (SBAR (IN that)
            (S
              (NP (NN HHV-8) (JJ infected) (JJ circulating) (NNS cells))
              (VP (VBP play)
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP (NN KS) (NN development) (CD -LSB-20,52,53))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (NN HHV-8))
      (VP (MD can)
        (VP (VB infect)
          (NP
            (NP (VBG circulating) (NN B) (NNS cells))
            (, ,)
            (NP (NNS monocytes/macrophages))
            (, ,)
            (NP (NN T) (NNS cells))
            (CC and)
            (NP (JJ KS-like) (NN spindle) (NN cell) (NNS progenitors)
              (NP (CD -LSB-54-56) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN KS) (NNS lesions)))
      (S
        (NP (NN B) (NNS cells))
        (VP (VBP are)
          (ADJP
            (ADJP (JJ rare))
            (CC or)
            (ADJP (JJ absent)))))
      (, ,)
      (CC but)
      (S
        (NP (NNS monocytes) (NNS macrophages))
        (VP (VBP are)
          (ADVP (RB abundantly))
          (ADJP (JJ present)
            (NP
              (NP (CD -LSB-52) (-RRB- -RSB-))
              (, ,)
              (NP
                (NP (DT this))
                (VP (VBP suggest)
                  (SBAR (IN that)
                    (S
                      (NP (VBG circulating) (NNS monocytes))
                      (VP (MD may)
                        (VP
                          (VP (VB recruit)
                            (NP (DT the) (NN virus))
                            (PP (IN into)
                              (NP (NNS tissues))))
                          (CC or)
                          (VP (VB transmit)
                            (NP (DT the) (NN virus))
                            (PP (TO to)
                              (NP (JJ other) (NNS cells)))))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP
            (NP
              (NP (NNS lymphocytes))
              (CC and)
              (NP (NNS monocytes)))
            (VP (VBG infiltrating)
              (NP (NN KS) (NNS lesions))))
          (VP (MD can)
            (VP (VB be)
              (VP
                (ADVP (RB productively))
                (VBN infected)
                (PP (IN by)
                  (NP (NN HHV-8) (CD -LSB-20,22))))))
          (-RRB- -RSB-)))
      (, ,)
      (NP (PRP it))
      (VP (VBZ is)
        (ADJP (JJ important)
          (PP (TO to)
            (NP
              (NP (NN look))
              (PP (IN at)
                (NP
                  (NP (JJ active) (NN infection))
                  (PP (IN in)
                    (NP (DT the) (NN PBMC))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS PBMCs))
        (PP (IN of)
          (NP (CD two) (NN AIDS-KS) (NNS patients))))
      (VP (VBD were)
        (VP
          (VP (VBN selected))
          (CC and)
          (VP (VBN analysed)
            (PP (IN for)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP (NN HHV-8) (NN mRNA)))))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In)
          (NP
            (NP (CD 90) (NN %))
            (PP (IN of)
              (NP (PRP$ our) (NNS samples)))))
        (, ,)
        (NP
          (NP (NN ORF) (CD 73) (NN mRNA))
          (CC and)
          (NP (NN vBcl-2) (NN mRNA)))
        (VP (VBD were)
          (VP (VBN detected))))
      (, ,) (IN whereas)
      (S
        (PP (IN for)
          (NP (NN vIL-6)))
        (NP
          (NP (NN mRNA))
          (CC and)
          (NP (NN vGCR) (NN mRNA)))
        (VP (VBD were)
          (ADJP (JJ present)
            (PP (IN in)
              (NP
                (NP (CD 60) (NN %))
                (CC and)
                (NP (CD 50) (NN %))
                (, ,)
                (ADVP (RB respectively))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN expression) (NNS levels))
        (PP (IN of)
          (NP (DT all) (CD four) (NNS genes))))
      (VP (VBD varied)
        (ADVP (RB widely))))
    (. .)))

(
  (S
    (S
      (S
        (VP
          (VP (VBG Comparing)
            (NP
              (NP (DT the) (JJ different) (NN expression) (NNS levels))
              (PP (IN of)
                (NP (DT the) (CD four) (NN HHV-8) (NNS genes))))
            (PP (IN within)
              (NP (CD one) (NN sample))))
          (CC or)
          (VP (VBG comparing)
            (NP
              (NP (NN expression) (NNS levels))
              (PP (IN of)
                (NP (CD one) (NN gene))))
            (PP (IN in)
              (NP (CD one) (NN patient))))))
      (VP (VBD did) (RB not)
        (VP (VB show)
          (NP (DT an) (JJ apparent) (NN tendency)))))
    (. .)))

(
  (S
    (S
      (NP (DT No) (JJ clear) (NN trend))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN distinguished)
            (PP (VBN based)
              (PP (IN on)
                (NP
                  (NP (DT the) (NN HHV-8) (NN DNA) (NNS levels))
                  (, ,)
                  (NP
                    (NP (NN patient))
                    (CC or)
                    (NP (NN disease) (NN status))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Nevertheless))
      (NP
        (NP (DT the) (NN finding))
        (PP (IN of)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP (JJ different) (NN HHV8) (JJ specific) (NNS genes)))
            (PP (IN in)
              (NP (NNS PBMCs))))))
      (VP (VBZ is)
        (ADJP (JJ notable)
          (PP (IN in)
            (NP (PRP itself))))
        (, ,)
        (SBAR (IN as)
          (S
            (NP (PRP it))
            (VP (VBZ has) (RB not)
              (VP (VBN been)
                (VP (VBN described)
                  (ADVP (IN before)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN HHV-8) (NN RNA))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN found)
            (PP (IN in)
              (NP
                (NP (NNS tissues))
                (, ,)
                (NP (JJ endothelial) (NNS cells))
                (CC and)
                (NP
                  (NP (NN spindle) (NNS cells))
                  (PRN (NN -LSB-18,57,58) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (CD 90) (NN %))
          (PP (IN of)
            (NP (JJ fresh) (JJ KS-affected) (NNS tissues)))))
      (, ,)
      (NP (NN HHV-8) (NN RNA))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN detected)
            (PP (IN with)
              (NP (NN RT-PCR) (CD -LSB-59))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (ADJP (FW In) (FW situ))
          (NN hybridisation))
        (CC and)
        (NP (NN LANA) (NN immunohistochemistry)))
      (VP (VBP have)
        (S
          (VP (VBD confirmed)
            (NP
              (NP (NN HHV-8) (NN gene) (NN expression))
              (PP (IN in)
                (NP (NN KS) (NN spindle) (NNS cells))))
            (PP (IN within)
              (NP (NN KS) (NNS lesions) (CD -LSB-18,58,60-62) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Expression))
        (PP (IN of)
          (NP (JJ lytic) (NN HHV-8) (NNS genes))))
      (VP (VBZ has)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN documented)
            (PP (IN in)
              (NP
                (NP (NNS monocytes))
                (CC and)
                (NP (NNS macrophages))))
            (PP (IN in)
              (NP (NN KS) (NNS lesions) (CD -LSB-20) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (NP (NN Conclusion))))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS assays))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBD were)
              (VP (VBN developed))))))
      (VP (VBP work)
        (ADVP (RB well))
        (PP (IN for)
          (NP
            (NP (DT the)
              (NP (NN detection))
              (CC and)
              (NP (NN quantification)))
            (PP (IN of)
              (NP (NN HHV-8) (JJ specific) (NN mRNA)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP
            (NP (DT no) (JJ clear) (NN trend))
            (PP (IN in)
              (NP (DT the) (NN expression) (NN pattern))))
          (VP (MD could)
            (VP (VB be)
              (VP (VBN distinguished)
                (NP
                  (NP (DT the) (NN finding))
                  (PP (IN of)
                    (NP
                      (NP (NN expression))
                      (PP (IN of)
                        (NP (JJ different) (NN HHV8) (JJ specific) (NNS genes)))
                      (PP (IN in)
                        (NP (NNS PBMCs)))))))))))
      (VP (VBZ is)
        (ADJP (JJ important)
          (PP (IN in)
            (NP (PRP itself))))))
    (. .)))

(
  (S
    (S (IN As)
      (S
        (NP (DT this))
        (VP (VBZ suggests)
          (SBAR (IN that)
            (S
              (NP (NN HHV-8) (NN replication))
              (VP (VBZ takes)
                (NP (NN place))
                (PP (IN in)
                  (NP (DT the) (NN PBMC)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (DT The) (NNS PBMCs))
          (NP (PRP we)))
        (VP (VBN used)))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN from)
            (NP (CD two) (NNS patients))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB draw)
            (NP
              (NP (NNS conclusions))
              (PP (IN about)
                (NP
                  (NP (DT the)
                    (ADJP
                      (ADJP (JJ clinical))
                      (CC and)
                      (ADJP (JJ prognostic)))
                    (NN utility))
                  (PP (IN of)
                    (NP (DT these) (NNS assays)))))))))
      (NP
        (NP (JJR more) (NNS patients))
        (CC and)
        (NP (NN patient) (NNS samples)))
      (VP (VBP need)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN analysed)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (SBAR (IN as)
        (S
          (NP (DT the) (NNS assays))
          (VP (VBP are)
            (ADJP (JJ able)
              (S
                (VP (TO to)
                  (VP (VB quantify)
                    (NP (NN HHV-8) (NN mRNA))
                    (PP (IN in)
                      (NP (NN PBMC) (NNS samples))))))))))
      (NP (PRP we))
      (VP (VBP feel)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT these) (JJ real-time) (NN NASBA) (NNS assays))
              (PP (IN with)
                (NP (NN beacon) (NN detection))))
            (VP (VBP provide)
              (NP
                (NP (NNS tools))
                (PP (IN for)
                  (NP
                    (NP (JJ further) (NN study))
                    (PP (IN of)
                      (NP
                        (NP (NN HHV-8) (NN expression))
                        (PP (IN in)
                          (NP (NN patient) (NN material)))))))))))))
    (. .)))

(
  (S
    (NP (VBG Competing) (NNS interests))))

(
  (S
    (S
      (NP (NN None))
      (VP (VBD declared)))
    (. .)))

(
  (S
    (NP
      (NP (NNS Authors) (POS '))
      (NNS contributions))))

(
  (S
    (S
      (NP (NN AP))
      (VP (VBD carried)
        (PRT (RP out))
        (NP
          (NP (DT the)
            (NP (NN assay) (NN development))
            (CC and)
            (NP (NN validation)))
          (, ,)
          (VP
            (VP (JJ preformed)
              (NP (DT the) (NN NASBA) (NNS experiments)))
            (CC and)
            (VP (VBN drafted)
              (NP (DT the) (NN manuscript)))))))
    (. .)))

(
  (S
    (S
      (NP (NN JG))
      (VP (VBD participated)
        (PP (IN in)
          (NP (DT the) (NN study) (NN design)))))
    (. .)))

(
  (S
    (S
      (NP (NN MC))
      (VP
        (VP (VBD participated)
          (PP (IN in)
            (NP (DT the) (NN study) (NN design))))
        (CC and)
        (VP (VBD carried)
          (PP (IN out)
            (NP (PRP$ its) (NN supervision))))))
    (. .)))

(
  (S
    (NP (NN Pre-publication) (NN history))))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ pre-publication) (NN history))
        (PP (IN for)
          (NP (DT this) (NN paper))))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN accessed)
            (ADVP (RB here))))))
    (: :)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (NP
      (NP (NN Figure) (CD 1))
      (: :)
      (NP
        (NP (NN NASBA) (NN amplification) (NN reaction) (NN NASBA) (NN amplification) (NN reaction))
        (PP (IN with)
          (NP (DT the)
            (NP (NN P1) (-LRB- -LRB-) (NN anti-sense) (-RRB- -RRB-) (NN –) (NN P2) (-LRB- -LRB-) (NN sense) (-RRB- -RRB-) (NN oligonucleotide))
            (NN primer) (NN set))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN overhang))
        (PP (IN on)
          (NP (DT the) (NN P1))))
      (VP (VBZ encodes)
        (NP
          (NP (DT the) (NN promoter) (NN sequence))
          (PP (IN for)
            (NP (DT the) (NN T7) (NN RNA) (NN polymerase))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (DT A) (JJ molecular) (NN beacon))
          (PP (IN with)
            (NP (DT a) (NN fluorophore))))
        (CC and)
        (NP
          (NP (DT a) (NN quencer))
          (PP (IN with)
            (NP (DT the) (NN NASBA) (NN amplification) (NN reaction)))))
      (VP (VBZ generates)
        (NP (DT a) (JJ real-time) (NN detection) (NN system))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 2))
      (: :)
      (NP
        (NP (JJ Standard) (NNS curves))
        (PP (IN in)
          (NP (FW vitro) (NN RNA) (NN Figure) (CD 2) (NN a-d))))
      (. .))))

(
  (S
    (NP
      (NP (NN Relationship))
      (PP (IN of)
        (NP
          (NP (NN time-to-positivity))
          (PRN (-LRB- -LRB-)
            (NP (NN TTP))
            (-RRB- -RRB-))))
      (PP (TO to)
        (NP (NN HHV-8) (NN mRNA) (NN copy) (NN number)))
      (. .))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN number))
        (PP (IN of)
          (NP
            (NP (NN mRNA) (NNS molecules))
            (ADJP (JJ present)
              (PP (IN in)
                (NP (DT the) (NN reaction)))))))
      (VP (VBZ is)
        (VP (VBN indicated)
          (PP (IN on)
            (NP
              (NP
                (NP (DT the) (NN x) (NN axis))
                (CC and)
                (NP (DT the) (NN ttp) (NN value)))
              (PP (IN in)
                (NP
                  (NP (VBN indicated))
                  (PP (IN on)
                    (NP (DT the) (NN y) (NN axis))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP
          (NP (DT the) (NNS data))
          (VP (VBN obtained)
            (PP (IN with)
              (NP
                (QP (CD 50) (, ,) (CD 102) (TO to) (CD 107))
                (NNS molecules))))))
      (, ,)
      (NP
        (NP (DT the) (NNS values))
        (PP (IN of)
          (NP (NN TTP))))
      (VP (VBP are)
        (NP
          (NP (DT the) (NN mean))
          (PP (IN of)
            (NP
              (NP
                (NP (CD five))
                (VBZ replicates))
              (PP (IN of)
                (NP (JJ independent) (NNS experiments))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (DT the) (NN U1A)))
      (NP
        (NP (DT the) (NN range))
        (PP (IN of)
          (NP (NN RNA) (NN input))))
      (VP (VBD was)
        (NP (CD 103) (TO to) (CD 108))))
    (. .)))

(
  (S
    (S
      (NP (NN Error) (NNS bars))
      (VP (VBP indicate)
        (NP
          (NP (DT the) (JJ standard) (NN deviation))
          (PP (IN for)
            (NP
              (NP (DT the) (NNS values))
              (PP (IN of)
                (NP (NN ttp))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (JJ solid) (NN line))
        (VP (VBD was)
          (VP (VBN obtained)
            (PP (IN by)
              (NP
                (NP (JJ linear) (NN regression) (NN analysis))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NNS data))
                    (PP (IN from)
                      (NP
                        (QP (CD 50) (TO to) (CD 107))
                        (NNS molecules))))))))))
      (, ,)
      (CC and)
      (S
        (NP (DT the) (JJ dotted) (NNS lines))
        (VP (VBP indicate)
          (NP
            (NP (DT the)
              (ADJP (CD 95) (NN %))
              (NN confidence) (NNS intervals))
            (PP (IN for)
              (NP (DT the) (NN regression)))))))
    (. .)))

(
  (S
    (S
      (VP (VBZ Inserts)
        (NP
          (NP (NN a-d) (: :) (NN Amplification) (NN plot))
          (PP (IN of)
            (NP
              (NP (DT a) (JJ 10-fold) (NN dilution) (JJ serial) (NN dilution))
              (PP (IN of)
                (NP
                  (ADJP (FW in) (FW vitro))
                  (NN RNA)))))
          (PP (IN for)
            (NP
              (NP (NN ORF) (CD 73))
              (, ,)
              (NP (NN vGCR))
              (, ,)
              (NP (NN vBcl-2))
              (CC and)
              (NP (NN vIL-6)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN amount))
        (PP (IN of)
          (NP
            (NP (NN input) (NN RNA) (CD 1) (NN *) (CD 107))
            (, ,)
            (NP (CD 1) (NN *) (CD 106))
            (, ,)
            (NP (CD 1) (NN *) (CD 105))
            (, ,)
            (NP (CD 1) (NN *) (CD 104))
            (, ,)
            (NP (CD 1) (NN *) (CD 103))
            (, ,)
            (NP (CD 1) (NN *)))))
      (NP
        (QP (CD 102) (, ,) (CD 50)
          (CC and)
          (CD 0))
        (NNS molecules)))
    (. .)))

(
  (S
    (NP
      (NP (NN Insert) (NN e))
      (: :)
      (NP
        (NP (NN Amplification) (NN plot))
        (PP (IN of)
          (NP
            (NP (DT a) (JJ 10-fold) (NN dilution) (JJ serial) (NN dilution))
            (PP (IN of)
              (NP (NN U1A)))))
        (PP (IN in)
          (NP (FW vitro) (NN RNA))))
      (, ,)
      (NP
        (NP (DT the) (NN amount))
        (PP (IN of)
          (NP
            (NP
              (NP (NN input) (NN RNA) (CD 1) (NN *) (CD 108))
              (, ,)
              (NP (CD 1) (NN *) (CD 107))
              (, ,)
              (NP (CD 1) (NN *) (CD 106))
              (, ,)
              (NP (CD 1) (NN *) (CD 105))
              (, ,)
              (NP (CD 1) (NN *) (CD 104))
              (, ,)
              (NP (CD 1) (NN *)
                (QP (CD 103)
                  (CC and)
                  (CD 0))))
            (NNS molecules))))
      (. .))))

(
  (S
    (NP
      (NP (NN Table) (CD 1))
      (: :)
      (NP
        (NP (NNS Primers))
        (PP (IN for)
          (NP
            (NP (NN PCR) (NN fragment))
            (PP (IN in)
              (NP (NNS plasmids)))))))))

(
  (S
    (NP
      (NP (NN Table) (CD 2))
      (: :)
      (NP
        (NP (NNS Sequences))
        (PP (IN of)
          (NP
            (NP (DT the)
              (NP (NNS primers))
              (CC and)
              (NP (NNS beacons)))
            (PP (IN for)
              (NP
                (NP (DT each))
                (PP (IN of)
                  (NP (DT the) (NNS assays)))))))))))

(
  (S
    (NP
      (NP (NN Table) (CD 3))
      (: :)
      (NP
        (NP (DT The) (NN ratio) (NN mRNA))
        (PP (IN of)
          (NP
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN HHV-8))
                (: /)
                (NP (NN U1A)))
              (-RRB- -RRB-))
            (NN ×) (CD 107)))))))

